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ABSTRACT 
Context: Infection is a major cause of morbidity and mortality in intensive care units 
worldwide. However, there is still relatively little information about the global 
epidemiology of such infections. 
Objective: To provide an up-to-date picture of the extent and patterns of infection in 
intensive care units around the world. 
Design: One-day point prevalence study on May 8, 2007. 
Setting: A total of 1265 intensive care units from 76 countries. 
Patients: All patients present on one of the participating units on the study day. 
Main outcome measures: Demographic, physiologic, bacteriological, and therapeutic data 
were collected, along with outcome data at intensive care unit and hospital discharge. 
Results: On the day of the study, 51% of patients were considered to be infected. 
Seventy-one percent of all patients were receiving antibiotics. Sixty-four percent of 
infections were of respiratory origin, and 70% of infected patients had positive 
microbiological isolates; Gram-negative organisms were isolated from 62% of infectious 
episodes, Gram-positive organisms from 47%, and fungi from 19%. Gram-negative 
organisms were much less prevalent in North America, Europe and Oceania than in other 
regions. Patients who had longer intensive care unit stays prior to the study day had 
higher rates of infection, especially infections due to resistant staphylococci, 
Acinetobacter, Pseudomonas species and fungi. Intensive care unit (25 versus 11%) and 
hospital (33% versus 15%) mortality rates were more than double in infected than in non-
infected patients (both P<0.001). In multivariable analysis, infection was independently 
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associated with an increased risk of hospital mortality (odds ratio 1.52 [1.37-1.69], 
P<0.001). 
Conclusions: Infections are very common in contemporary intensive care unit patients, 
and risk of infection increases with duration of intensive care unit stay. In this large 
cohort, infection was independently associated with an increased risk of hospital death. 
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Introduction 
Infection is a common problem for patients in intensive care units (ICUs), and is 
associated with considerable morbidity, mortality, and costs.1-11 Infection and related 
sepsis are the leading cause of death in non-cardiac ICUs, with mortality rates that reach 
60%, and account for approximately 40% of total ICU expenditure.10,12 Importantly, the 
incidence of sepsis and, hence, the number of infection-related deaths is increasing.5,13  
Most large epidemiological studies of infection and sepsis have been conducted in 
North America, Europe, and Australia 2,10,13-18, with limited data from other countries.19,20 
Differing definitions and different study populations make it difficult to compare study 
results. International data related to the prevalence, risk factors, causative 
microorganisms, and outcomes of infection are necessary to increase and maintain 
awareness of the impact of infection, to help in the development of local and international 
guidelines for diagnosis and treatment, to facilitate adequate and appropriate resource 
allocation, and to assist in the design of multicenter interventional studies.  
The European Prevalence of Infection in intensive Care (EPIC) study,21 
conducted on April 29, 1992, included data from 1417 ICUs in 17 Western European 
countries and provided valuable information regarding the prevalence and epidemiology 
of infection in European critically ill patients. Fifteen years after that successful 
international collaboration, EPIC II, the Extended Prevalence of Infection in Intensive 
Care study, was conducted to provide an up-to-date picture of the extent and patterns of 




A international steering committee was established in 2006 and selected the study date, 
May 8, 2007. ICUs were invited to participate in a one-day, prospective, multicenter 
prevalence study of ICU infection. Methods for recruitment of participating institutions 
included direct mailings to members of the European Society of Intensive Care Medicine, 
announcements at international meetings and symposia, and mailings to contacts and 
collaborators of each steering committee member. Participation in the study was entirely 
voluntary and the study was not funded. Local ethical committee approval at each 
participating center was expedited or waived due to the purely observational nature of the 
study. 
Demographic, physiologic, bacteriological, and therapeutic data were collected 
from all patients present on a participating ICU between midnight on May 7 and midnight 
on May 8, 2007. SAPS II22  and sequential organ failure assessment (SOFA)23 scores 
were calculated for the study day. Outcomes at ICU and hospital discharge, and any 
decision to withdraw/withhold therapy during the ICU stay were also recorded. Data 
were recorded using pre-printed case report forms (CRF) and were not monitored. A 
dedicated telephone hotline was available for any queries during the study follow-up 
period. 
Infection was defined according to the definitions of the International Sepsis 
Forum24 and adjudicated by the attending physician. Patients who had had surgery in the 
4 weeks preceding admission were considered to be surgical admissions. Elective surgery 
was defined as surgery scheduled > 24 hours in advance and emergency surgery as that 
scheduled within 24 hours of operation. Trauma was defined as ICU admissions directly 
related to, or occurring as a complication of, a traumatic event in the 30 days preceding 
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admission. All other admissions were considered medical. The presence of the following 
comorbid conditions was noted: Chronic obstructive pulmonary disease (COPD); 
metastatic cancer (metastases proven by surgery, computed tomography or magnetic 
resonance scan, or any other method); liver cirrhosis; heart failure (NYHA III-IV); 
hematologic malignancy (lymphoma, acute leukemia, or multiple myeloma); human 
immunodeficiency virus (HIV) infection (HIV positive patients with clinical 
complications such as Pneumocystis jirovecii, Kaposi’s sarcoma, lymphoma, 
tuberculosis, or toxoplasma infection); chronic renal failure (need for chronic renal 
support or history of chronic renal insufficiency with a serum creatinine > 3.6 gm/dL [300 
µmol/L]); immunosuppression (administration in the 6 months prior to ICU admission of 
steroid treatment [at least 0.3 mg/kg/day prednisolone for at least one month], severe 
malnutrition, congenital immunohumoral or cellular immune deficiency state); 
chemotherapy/radiotherapy (in the 6 months prior to ICU admission); insulin-requiring 
diabetes mellitus (the need, prior to ICU admission, for insulin injections to control blood 
sugar levels).   
For the purposes of the analysis, the world was divided into 7 geographical 
regions: North America, Central and South America, Western Europe, Eastern Europe, 
Asia, Oceania, and Africa. Data on health care expenditure in the various countries were 
obtained from the World Health Organization 
(http://www.who.int/whosis/whostat/EN_WHS09_Full.pdf), generated using the WHO 





All data were analyzed in the Department of Intensive Care of the University of Brussels, 
Belgium, in collaboration with the University of Jena, Germany. Statistical analyses were 
performed using SPSS for windows version 13.0 (SPSS Inc, Chicago, USA). The 
Kolmogorov-Smirnov test was used, and histograms and normal-quantile plots were 
examined to verify if there were significant deviations from the normality assumption of 
continuous variables. Non-parametric tests of comparison were used for variables 
evaluated as not normally distributed. Difference testing between groups was performed 
using ANOVA, Kruskal Wallis, Student’s t-test, Mann-Whitney test, Chi square test and 
Fisher exact test as appropriate. A Bonferroni correction was made for multiple 
comparisons. Multivariable logistic regression analysis was used to determine risks 
factors for infection and hospital mortality. The following variables were investigated as 
independent risk factors: Type of admission, source of admission, comorbidities, age, sex, 
mechanical ventilation, hemofiltration or hemodialysis, infection, SAPS II score, type of 
microorganism. The odds ratios were adjusted for hospital- and organizational-related 
factors, including type of ICU (closed versus open, community versus university; surgical 
versus medical), number of ICU beds, number of nurses, number of physiotherapists, 
presence of 24h ICU physician, percentage of gross domestic product spent on healthcare 
(obtained from the World Health Organization 
[http://www.who.int/whosis/whostat/EN_WHS09_Full.pdf], generated using the WHO 
Statistical Information System and based on data from 2006), length of ICU stay prior to 
study day, and geographical region. Data are presented as mean ± SD, median value 
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(25th -75th interquartile ranges) or number (%) as appropriate. All statistics were two-
tailed and a p < 0.05 was considered to be statistically significant.    
 
Results 
Characteristics of the study group  
EPIC recruited 1265 ICUs in 76 countries (see Appendix for list of participating ICUs) . 
The greatest number of patients came from Western Europe, but the countries with more 
than 150 participating ICUs were Germany, Spain, Brazil, United Kingdom, United 
States, and Italy. University hospitals accounted for 60% of the total participating 
hospitals; 66% were mixed medical-surgical ICUs and 94% had 24-hour ICU physician 
cover. Characteristics of the ICUs are presented in Table 1.  
On the study day, 14,414 patients were present on one of the participating ICUs; 
their demographic characteristics are presented in Table 2. Sixty-two percent of the 
patients were male, 61% were surgical admissions, and 50% of the patients had at least 
one comorbidity.  
 
Prevalence and characteristics of infections 
Of the 14,414 patients, 7330 (51%) were considered to be infected on the day of the study, 
and 71% of all patients were receiving antibiotics. Of the infected patients, 16% were 
being treated with antifungal agents. Infected patients were older, had more co-morbid 
conditions, and had higher SAPS II scores on admission than non-infected patients (Table 
2). Greece and Portugal had the highest infection rates (65% each), and Switzerland 
(46%), Germany (43%), and the Netherlands (39%) had the lowest rates (P<0.05) (Table 
3). The lungs were the most common site of infection, accounting for 64% of infections, 
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followed by abdominal (19%) and blood stream (15%) infections (Table 4). Seventy 
percent of infected patients had positive microbial isolates; 47% of infections were 
associated with Gram-positive isolates and 62% with Gram-negative isolates (Table 4). 
Nineteen percent of infected patients had isolates positive for fungi. In patients with 
positive isolates, the most commonly Gram-positive organism was Staphylococcus 
aureus (20%) and the most common Gram-negative organisms were Pseudomonas 
species (20%) and Escherichia coli (16%) (Table 5). There was considerable variation in 
the types of organisms isolated among the different geographical regions; for example, in 
Africa 21% of positive isolates were methicillin-resistant S. aureus (MRSA), while in 
Western Europe and Oceania the percentage was only 9 (P<0.05). The proportion of 
Gram-negative organisms was much greater in Asia, Western Europe and Latin America 
than in North America, Europe or Oceania.  
 
Factors associated with higher risk of infections 
The infection rate was related to disease severity as expressed by the SAPS II score and 
the degree of organ failure (Fig. 1). There was a relationship between the number of days 
spent in the ICU before the study day and the rate of infections: The infection rate 
increased from 32% for patients with a pre-study day ICU stay of 0-1 days to more than 
70% for patients with a pre-study day ICU stay of more than 7 days (r2=0.89, p= 0.005) 
(Fig. 2). This was particularly true for infections with MRSA, Acinetobacter spp, 
Pseudomonas spp and fungi. The rate of infection was related to health care expenditure, 
with countries which had a lower proportion of national product devoted to health care 
having higher rates of infection (Fig. 3). 
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In a multivariable logistic regression analysis, medical admission, admission after 
emergency surgery or trauma, referral from the hospital floor, emergency room (ER), or 
other hospital (with referral from the operating room [OR] as a reference), the presence 
of COPD, cancer, HIV, older age, mechanical ventilation and renal replacement therapy 
on the study day, and greater SAPS II scores were independently associated with a higher 
risk of infection (Table 6) 
 
Mortality and morbidity 
The ICU and hospital mortality rates for all patients were 17.9 and 23.7%, respectively, 
and were highest in ICUs from Central & South America and Eastern Europe and lowest 
in ICUs from Oceania (Table 7). Infected patients had higher ICU and hospital mortality 
rates (25.0 vs 10.5%, and 32.6 vs 14.5%, respectively, p < 0.001 for both) and lower ICU 
and hospital lengths of stay ( 4 [1-14] vs 16 [7-34] days and 13 [7-31] vs 29 [14-57], 
respectively, p < 0.001 for both) than those who did not have infections. Decisions to 
withhold or withdraw life-sustaining measures were made in 1269 patients (8.8%) and 
were more common in infected than non-infected patients (27.2 vs 14.2%, P < 0.001). 
There was also a significant relationship between the percentage of infected patients and 
the ICU and hospital mortality rates (Figure 4).  
In a multivariable analysis of all patients, with hospital mortality as the dependent 
variable and adjusting for possible confounders, infection was independently associated 
with a greater risk of hospital mortality (OR: 1.52, 95% CI: 1.37-1.69, P<0.001). Other 
factors associated independently with a greater higher risk of in-hospital death are shown 
in Table 8. In patients with infections, factors independently associated with a greater risk 
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of hospital death included infection with Pseudomonas or Acinetobacter spp., cancer or 
cirrhosis as comorbidities, older age, and greater disease severity (Table 9).     
  
Discussion 
The data from this large international collaboration highlight the common occurrence of 
infections in contemporary ICUs, with 45-60% of ICU patients being classified by the 
attending physician as infected on the day of the study. Infected patients were older, had 
more comorbid conditions, and had higher SAPS II scores on admission.  
As in other recent epidemiological studies,1-9,19,25 the most common focus of 
infection in patients in our study was the lung, followed by the abdomen and blood 
stream. Interestingly, although studies have suggested an increasing incidence of Gram-
positive organisms26 and the SOAP study reported an equal frequency of Gram-positive 
and -negative organisms,1 in the present study Gram-negative organisms were more 
commonly isolated than Gram-positive organisms, although these differences were most 
marked in Eastern Europe, Asia, and Central & South America. Patterns of infecting 
organisms were also similar to previous studies with predominant organisms being S. 
aureus, including MRSA, Pseudomonas spp, Enterobacteriaceae (mainly E. coli) and 
fungi.1 Interestingly, Acinetobacter was involved in 9% of all infections, similar to the 
rate reported in the first EPIC study,27 but considerably higher than the 3.6% reported in 
the more recent SOAP study.1 In multivariable analysis, infection with Acinetobacter was 
associated with an increased risk of hospital death. Given the high level of resistance of 
Acinetobacter to many antibiotics, including carbapenems, and the high associated 
mortality,28 this pathogen represents a continuing challenge in today’s ICU. Infections 
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with Pseudomonas spp were also associated with an increased risk of in-hospital death as 
has been reported in the SOAP study.1   
EPIC II was conducted 15 years after the original EPIC study,21 which was 
limited to Western Europe and included just over 10,000 patients. In contrast to the EPIC 
study, we did not focus our analysis on nosocomial infections, as we were concerned that 
the distinction between community-acquired, hospital acquired and ICU-acquired 
infections may be difficult to achieve. As in the EPIC study,21 and more recently the 
SOAP study,1 there was a relationship between the prevalence of infection and mortality 
for the various countries. Importantly, this relationship was present overall, but also for 
countries of Western Europe, which represent a more homogeneous region, and 
contributed most patients to this study. We also noted a significant relationship between 
the time spent in the ICU prior to the study day and the development of infection, 
particularly for infections due to MRSA, Acinetobacter, Pseudomonas species, and fungi.  
The study also revealed important differences in outcomes in various parts of the 
world. For example, mortality rates were lower in Oceania, both overall and in infected 
patients, than in other regions. The reasons for this are not entirely clear although 
differences in patient characteristics are likely to be at least in part responsible. It is also 
possible that a lead time bias may play a role, in that patients may be admitted earlier to 
the ICU in some regions than in others. The huge variability in critical care services 
among North American and European countries, with wide differences in both numbers 
of beds and volume of admissions, has also been recently highlighted29 and is likely to be 
responsible for some of the regional differences in our data.  
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Interestingly, the rate of infection was related to the proportion of gross domestic 
product allocated to health care expenses, as countries with a lower health expenditure 
had higher rates of infection. Although our data do not allow us to offer a definitive 
explanation for this observation, it is interesting to speculate that countries with lower 
health care expenditure will have limitations on the number of ICU beds, which will 
therefore be occupied by more severely ill patients who are more likely to be infected. 
There are few data available on this topic. One recent report,29 although reporting only a 
weak correlation between ICU beds per 100,000 population and healthcare spending per 
capita in 8 countries, did note an inverse correlation between the provision of ICU beds 
and the frequency of sepsis and hospital mortality using data from two large independent 
sources, the SOAP study1 and the SAPS 3 database.30  
Our study has advantages and limitations. An obvious strength is the international 
nature of the study collecting data on patterns of infection in a large and diverse group of 
patients across all geographical boundaries. A worldwide study has the advantage that 
differences in practice patterns can be used to probe independent influences of patient 
and management factors on epidemiology and outcome. The study was not funded, 
because we preferred to limit any possibility of industry influence. The size of this 
collaboration stresses the importance of the topic, and the desire to contribute to 
international projects without financial incentive. However, the voluntary nature of the 
study can be a potential source of bias. Moreover, the high proportion of university 
hospitals may have led to a patient case-mix that is not representative of all ICUs. 
Another disadvantage is that there was no data monitoring and results relied on the 
correct interpretation and use of the various definitions provided. A prevalence study has 
 14 
the advantage of requiring a relatively limited data set while including a large number of 
patients; however, prevalence studies can overestimate the number of patients with 
diseases of long duration, such as sepsis. Finally, although the study dates was chosen to 
minimize as far as possible seasonal effects, in the northern and southern hemispheres, 
there is no way to be completely sure that such effects did not influence the results.  
 
Conclusion 
The EPIC II study demonstrates that, 15 years after the EPIC 1 study, infections remain a 
common problem in ICU patients. There is a strong relation between presence of 
infection, and length of ICU stay and mortality, and a significant inverse relation between 
the prevalence of infections and extent of government health care expenditure. There are 
major international differences in the prevalence of infections, in the type of 
microorganisms, and in mortality rates. These important data provide us with a picture of 
patterns of infection around the world, which can enhance our understanding of global 
and regional differences, and provide pointers to help optimize infection prophylaxis and 
management.   
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Fig. 1. Relationship between rate of infection and disease severity and number of organs 
failing. 
Fig. 2. Relationship between rate of infection and the duration of stay in the ICU before 
the study day for all infections (upper panel) and for infections with Pseudomonas 
species, MRSA, fungi, Acinetobacter, Candida, Klebsiella species, E. coli and S. aureus 
(lower panel). Spearman Rank Correlation Coefficient = 0.89, p-value = 0.005 (upper 
panel). 
Fig. 3. Relationship between rate of infection and the total expenditure on health as % of 
Gross domestic product (GDP). 
Fig. 4. Relationship between frequency of infection and hospital mortality for the 
countries contributing patients from more than 150 ICUs: Argentina (AR), Australia 
(AU), Austria (AT), Belgium (BE), Brazil (BR), Canada (CA), Colombia (CO), Czech 
Republic (CZ), France (FR), Germany (DE), Greece (GR), India (IN), Italy (IT), 
Netherlands (NL), Portugal (PT), Scandinavia (SCAN), Spain (ES), Switzerland (CH), 
Turkey (TR), United Kingdom (GB), United States (US).
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Table 1. Characteristics of the contributing centers (n = 1265) 
Characteristic Number (%) 
Type of hospital (%)   
   University/academic 756 (60.4) 
   Non-university 496 (39.6) 
Hospital bed capacity,  median [IQ] 477 [240-830] 
Population (%)  
   Adult 957 (75.7) 
   Pediatric 34 (2.7) 
   Both 273 (21.6) 
Type of ICU (%)  
   Closed 1046 (83.8) 
   Open 211 (16.8) 
ICU specialty (%)  
   Surgical 214 (17.3) 
   Medical 133 (10.7) 
   Mixed 813 (65.6) 
   Others 80 (6.5) 
Microbiology 24h/24h, n (%) 903 (71.6) 
Emergency department 24h/24h, n (%) 1216 (96.2) 
ICU physician 24h /24h, n (%) 1189 (94.1) 
Number of ICU patients (2006), median [IQ]  684 [408-1100] 
ICU mortality rate (2006), median [IQ] 12 [7-20] 
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Valid percentages are displayed after exclusion of missing values 
Missing: Type of hospital=13, Population=1, Type of ICU=6, ICU specialty=25  
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Table 2. Basic characteristics of the study group   
Characteristic All patients 
N=14141 
Not infected  
N=6881 
Infected 
N=7330 P value 
Age, years, median [IQ] (63 [47-74]) 62 [47-73] 63 [48-74] 0.001 
Age (adult patients only), years, median 
[IQ] (64 [50-74]) 63 [50-74] 64 [50-74] 0.166 
Male, n (%)  8924 (61.9) 1678 (23.9) 2383 (32.6) 0.082 
Severity scores on the study day, 
mean±SD (median [IQ])     
       SAPS II score 34.8±15.5 (33 [24-43]) 29 [21-38] 36 [27-48] <0.001 
       SOFA score 6.3±4.0 (6 [3-9]) 5 [2-7] 6 [4-10] <0.001 
Type of admission (%)    <0.001 
   Medical 4061 (28.3) 1678 (23.9) 2383 (32.6)  
   Surgical:  Elective  3355 (23.4) 2400 (34.2) 955 (13.1)  
                   Emergency 5455 (38) 2144 (30.5) 3311 (45.3)  
   Trauma 1468 (10.2) 801 (11.4) 667 (9.1)  
Reason for ICU admission    <0.001 
   Respiratory 3269 (22.7) 916 (12.9) 2353 (32.1)  
   Cardiovascular 3133 (21.7) 1605 (22.7) 1528 (20.8)  
   Surveillance/monitoring 2726 (18.9) 2071 (29.2) 655 (8.9)  
   Neurological 2102 (14.6) 1041 (14.7) 1061 (14.5)  
   Digestive/liver 1329 (9.2) 492 (6.9) 837 (11.4)  
   Trauma 1200 (8.3) 655 (9.2) 545 (7.4)  
   Renal 326 (2.3) 120 (1.7) 206 (2.8)  
   Others* 329 (2.3) 184 (2.6) 145 (2)  
Source of admission    <0.001 
   ER/ambulance 4152 (29.1) 2067 (29.7) 2085 (28.6)  
   Hospital floor 3933 (27.6) 1579 (22.7) 2354 (32.3)  
   OR/recovery 3651 (25.6) 2269 (32.6) 1382 (19)  
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   Other hospital 2073 (14.5) 838 (12) 1235 (17)  
   Other 443 (3.1) 217 (3.1) 226 (3.1)  
Comorbidities, n (%)     
       COPD 2313 (16) 877 (12.4) 1436 (19.6) <0.001 
       Cancer 2110 (14.6) 985 (13.9) 1125 (15.3) 0.014 
       Heart Failure (NYHA III-IV) 1392 (9.7) 632 (8.9) 760 (10.4) 0.003 
       Diabetes mellitus 1340 (9.3) 609 (8.6) 731 (10) 0.005 
       Chronic renal failure 1253 (8.7) 496 (7) 757 (10.3) <0.001 
       Cirrhosis 463 (3.2) 196 (2.8) 267 (3.6) 0.003 
       Hematologic cancer 290 (2) 74 (1) 216 (2.9) <0.001 
       HIV 97 (0.7) 19 (0.3) 78 (1.1) <0.001 
Number of comorbidities, n (%)    <0.001 
    None 7176 (49.8) 3935 (55.5) 3241 (44.2)  
    1 4530 (31.4) 2130 (30.1) 2400 (32.7)  
    2 1855 (12.9) 730 (10.3) 1125 (15.3)  
    3 629 (4.4) 230 (3.2) 399 (5.4)  
   >3 224 (1.5) 59 (0.8) 165 (2.3)  
ER: emergency room; OR: operating room; COPD: chronic obstructive pulmonary disease; HIV: human immunodeficiency virus; 
*Metabolic/hematologic/obstetric and gynecology
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Table 3. Characteristics of infected patients according to geographical region 
 
 
a446 missing; *P < 0.05 vs Western Europe 









Oceania Africa Asia 
       n (%) 7330 (50.9) 3752 (48.6) 473 (56.4) 1325 (60.1) 616 (48.2) 315 (45.5) 92 (43.8) 757 (51.6) 
Age, mean ± SD  59.1±19.6 61.4 ±17.5 52.7 ±23.5*  59.1 ± 20.9* 56.9 ±18.8* 55.5 ± 22.9* 48.3 ±19.3*  55.9 ± 21.8* 
Sex, male  4599 (65.6) 2460 (64.2) 291 (61.5) 773 (58.3)* 361 (59.1)* 190 (60.3) 58 (63.0) 466 (61.6) 
SAPS II score, mean ±SD  38.5 ±15.7 38.4 ±15.3 36 ± 16.4* 41.4 ± 16.2* 37.8 ± 16 33.3 ± 13* 34 ±14.9* 38.8 ± 16.4 
SOFA score, mean ± SD  7.2 ±4.2 7.2 ±4.2 6.8 ± 4.2 7.2 ± 4.4 7.8 ± 4.2 6.4 ± 3.8* 7.6 ±3.7 7.3 ± 4.1 
ICU mortality, n (%)a   1724 (25) 810 (22.7) 136 (30.8)* 146 (34.6)* 110 (18.3) 43 (13.7)* 25 (28.1) 193 (27.5)* 
Hospital mortality (%)a   2242 (32.6) 1086 (30.7) 162 (36.7) 509 (42.3)* 147 (24.5)* 64 (20.4)* 29 (32.6) 245 (34.9) 
ICU length of stay, median [IQ] 16 [7 - 34] 19 [7-36] 19 [8-40] 17 [8-33] 11 [4-24]* 11 [5-20]* 12 [5-24]* 15 [7-33]* 
Hospital LOS. median [IQ]  29 [14-57] 33 [17-62] 30 [14-62] 27 [13-56]* 19 [9-41]* 25 [12-49]* 21 [10-34]* 24 [12-51]* 
Days in ICU before the study 
day, median [IQ]  
6 [1 - 15] 7[2-17] 7[1-17] 6[1-15] 4[1-12]* 6[2-11]* 3[0-10]* 5[1-14]* 
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Table 4. Site of infection and major microbiologic isolates according to geographical region 
 









Oceania Africa Asia 
N 7330 3752 473 1325 616 315 92 757 
Site of infection, n (%)         
        Respiratory  4658 (63.5) 2371 (63.2) 335 (70.8) 879 (66.3) 350 (56.8)* 179 (56.8) 43 (46.7)* 501 (66.2) 
        Abdominal  1417 (19.3) 790 (21.1) 95 (20.1) 230 (17.4)* 102 (16.6)  54 (17.1) 16 (17.4) 130 (17.2) 
        Blood stream  1108 (15.1) 555 (14.8) 62 (13.1) 143 (10.8)* 159 (25.8)* 54 (17.1) 16 (17.4) 119 (15.7) 
        Renal/urinary tract  1028 (14) 415 (11.1) 85 (18)* 226 (17.1)* 138 (22.4)* 37 (11.7) 15 (16.3) 112 (14.8)* 
        Skin  485 (6.6) 248 (6.6) 39 (8.2) 73 (5.5) 28 (4.5) 33 (10.5) 8 (8.7) 56 (7.4) 
        Catheter-related 343 (4.7) 176 (4.7) 24 (5.1) 74 (5.6) 17 (2.8) 15 (4.8) 4 (4.3) 33 (4.4) 
        CNS  233 (3.2) 106 (2.8) 25 (5.3)* 43 (3.2) 15 (2.4) 17 (5.4) 4 (4.3) 23 (3) 
        Others  561 (7.7) 297 (7.9) 40 (8.5) 86 (6.5) 62 (10.1) 24 (7.6) 15 (16.3) 37 (4.9)* 
Microorganisms, n (%)         
        Positive isolates  5106 (69.6) 2728 (72.7) 384 (81.2)* 741 (55.9)* 465 (75.5) 225 (71.4) 57 (62) 505 (66.7)* 
        Gram-positive  2399 (47) 1345 (49.3) 195 (50.8) 286 (38.5)* 257 (55.3) 119 (52.9) 29 (50.9) 168 (33.3)* 
        Gram-negative  3165 (62) 1599 (58.6) 275 (71.6)* 522 (70.4)* 233 (50.1)* 127 (56.4) 33 (57.9) 376 (74.5)* 
        Anaerobes  225 (4.4) 145 (5.3) 12 (3.1) 10 (1.3)* 36 (7.7) 7 (3.1) 1 (1.8) 14 (2.8) 
        Fungi  945 (18.5) 548 (20.1) 74 (19.3) 104 (14)* 96 (20.6) 32 (14.2) 6 (10.5) 85 (16.8) 
        Viral/parasitic 135 (2.6) 36 (1.4) 9 (2.3) 13 (1.7) 15 (3.2) 4 (1.8) 0.0 (0.0) 13 (2.6) 
        Others 110 (2.2) 68 (2.5) 4(1) 12 (1.6) 11 (2.4) 5 (2.2) 2 (3.5) 8 (1.6) 
 28 
*P < 0.05 vs Western Europe. 
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Table 5. Types of organisms in culture-positive infected patients according to geographical region 
 









Oceania Africa Asia 
Gram-positive                 
Staphylococcus aureus 1024 (20.5) 536 (19.6) 85 (22.1) 143 (19.3) 127 (27.3)* 60 (26.7) 17 (29.8) 78 (15.4) 
MRSA 524 (10.3) 237 (8.7) 42 (10.9) 83 (11.2) 81 (17.4)* 20 (8.9) 12 (21.1)* 49 (9.7) 
S. epidermidis 557 (10.9) 312 (11.4) 45 (11.7) 72 (9.7) 57 (12.3) 18 (8) 8 (14) 45 (8.9) 
S. pneumoniae 212 (4.2) 132 (4.8) 16 (4.2) 25 (3.4) 20 (4.3) 8 (3.6) 3 (5.3) 8 (1.6)* 
Enterococcus 542 (10.6) 364 (13.3) 51 (13.3)  32 (4.3)* 46 (9.9) 21 (9.3) 1 (1.8)* 27 (5.3)* 
others 336 (6.6) 187 (6.9) 15 (3.9)* 32 (4.3)* 50 (10.8)* 25 (11.1)* 4 (7) 23 (4.6) 
Gram-negative         
E. coli 814 (15.9) 468 (17.2) 56 (14.6) 104 (14) 66 (14.2) 27 (12) 6 (10.5) 87 (17.2) 
Enterobacter 353 (6.9) 189 (6.9) 29 (7.6) 62 (8.4) 38 (8.2) 8 (3.6) 4 (7) 23 (4.6) 
Klebsiella spp 645 (12.6) 264 (9.7) 82 (21.4)* 121 (16.3)* 41 (8.8) 25 (11.1) 10 (17.5) 102 (20.2)* 
Pseudomonas spp 1010 (19.8) 460 (16.9) 108 (28.1)* 194 (26.2)* 62 (13.3) 31 (13.8) 10 (17.5) 145 (28.7)* 
Acinetobacter spp 454 (8.9) 152 (5.6) 67 (17.4)* 103 (13.9)* 18 (3.9) 9 (4) 9 (15.8)* 96 (19)* 
others 862 (16.9) 495 (18.1) 57 (14.8) 124 (16.7) 52 (11.2)* 45 (20) 11 (19.3) 78 (15.4) 
Anaerobes 225 (4.4) 145 (5.3) 12 (3.1) 10 (1.3)* 36 (7.7) 7 (3.1) 1 (1.8) 14 (2.8) 
Other bacteria 82 (1.6) 34 (1.2) 10 (2.6) 14 (1.9) 4 (0.9) 4 (1.8) 3 (5.3) 13 (2.6) 
Fungi         
Candida 859 (16.8) 502 (18.4) 69 (18) 93 (12.6)* 83 (17.8) 28 (12.4) 6 (10.5) 78 (15.4) 
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Aspergillus 71 (1.4) 44 (1.6) 1 (0.3) 5 (0.7) 12 (2.6) 3 (1.3) 0 (0) 6 (1.2) 
others 50 (1) 22 (0.8) 5 (1.3) 7 (0.9) 10 (2.2) 2 (0.9) 0 (0) 4 (0.8) 
Parasites 36 (0.7) 18 (0.7) 2 (0.5) 6 (0.8) 3 (0.6) 2 (0.9) 0 (0) 5 (1) 
Other organisms 207 (4.1) 126 (4.6) 11 (2.9) 18 (2.4)* 22 (4.7) 12 (5.3) 2 (3.5) 16 (3.2) 
MRSA: methicillin-resistant S. aureus; *P < 0.05 vs Western Europe 
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Table 6. Multivariable logistic regression analysis with infection as the dependent 
variablea 
 
  OR (95% CI) P value 
Type of admission    
       Elective surgery Reference NA 
       Medical admission 2.31 (2.01-2.65) <0.001 
       Emergency surgery 2.94 (2.61-3.32) <0.001 
       Trauma 1.70 (1.43-2.01) <0.001 
Source of admission   
       OR/recovery Reference NA 
       ER/ambulance 0.86 (0.76-0.98) 0.023 
       Hospital floor 1.35 (1.20-1.52) <0.001 
       Other hospital 1.17 (1.02-1.35) 0.029 
Comorbidities   
       COPD 1.51 (1.35-1.69) <0.001 
       Cancer 1.26 (1.11-1.43) <0.001 
       Heart failure (NYHA III-IV) 0.97 (0.84-1.11) 0.640 
       Diabetes mellitus 1.14 (1.00-1.31) 0.057 
       Chronic renal failure 1.14 (0.98-1.32) 0.092 
       Cirrhosis 0.94 (0.75-1.17) 0.567 
       Hematologic cancer 1.39 (1.01-1.92) 0.046 
       HIV 3.79 (2.04-7.05) <0.001 
Age (per year) 1.00 (0.99-1.00) 0.003 
Male gender 1.08 (1.00-1.17) 0.062 
Mechanical ventilation 1.70 (1.56-1.85) <0.001 
Hemodialysis/hemofiltration 1.49 (1.27-1.75) <0.001 
SAPS II (per point) 1.02 (1.02-1.02) <0.001 
aAdjusted for hospital and organizational factors and for geographic region. 
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Table 7. Severity scores, infection rates and outcome according to geographical region 
 









Pacific Africa Asia 
Centers, n 1265 667 (52.7) 97 (7.7) 209 (16.5) 83 (6.6) 54 (4.3) 17 (1.3) 138 (10.9) 
Patients, n (%) 14414 7725 (53.6) 838 (5.8) 2204 (15.3) 1279 (8.9) 692 (4.8) 210 (1.5) 1466 (10.2) 
Age, mean ± SD  58.4±20.2 60.9 ±18.3 53.0 ±23*  58.5 ± 20.9* 56.6 ±19.0* 53.0 ± 25.3* 46.2 ±21.3*  53.7 ± 22.3* 
Sex, male  8924 (62.1) 4937 (64.2) 529 (63.1) 1252 (56.9)* 728 (57.3)* 417 (60.3) 143 (68.1) 918 (62.7) 
Type of admission          
Medical 4061 (28.3) 1822 (23.7) 175 (20.9) 890 (40.5)* 478 (37.5)* 195 (28.3) 66 (31.4) 435 (29.8)* 
Surgical         
Elective 3355 (23.4) 2036 (26.5) 235 (28.1) 347 (15.8)* 221 (17.4)* 190 (27.6) 37 (17.6)* 289 (19.8)* 
Emergency 5455 (38) 3051 (39.8) 338 (40.4) 767 (34.9)* 397 (31.2)* 229 (33.2)* 81 (38.6) 592 (40.5) 
Trauma 1468 (10.2) 763 (9.9) 88 (10.5) 195 (8.9)* 177 (13.9) 75 (10.9) 26 (12.4) 144 (9.9) 
Mechanical ventilation 8056 (56.3) 4410 (57.6) 459 (55) 1231 (56.2) 689 (54.1) 381 (55.1) 105 (50.2) 781 (53.6)* 
Hemodialysis/hemofiltration 1255(8.8) 684 (8.9) 44 (5.3)* 215 (9.8) 126 (9.9) 44 (6.4) 18 (8.6) 124 (8.5) 
Infected  7330 (50.9) 3752 (48.6) 473 (56.4)* 1325 (60.1)* 616 (48.2) 315 (45.5) 92 (43.8) 757 (51.6) 
Clinical infection  2225 (15.4) 1024 (13.3) 89 (10.6) 584 (26.5)* 151 (11.8) 90 (13) 35 (16.7) 252 (17.2)* 
Infected + microorganisms  5105 (35.4) 2728 (35.3) 384 (45.8)* 741 (33.6) 465 (36.4) 225 (32.5) 57 (27.1) 505 (34.4) 
SAPS II score,   mean ± SD  34.8±15.5 35 ±15.1 33.6 ±16  37.3 ± 16.3* 34.1 ±15.6 30.7 ± 12.7* 32.1 ±16.8*  33.5 ± 16.5* 
SOFA score, mean ± SD  6.3±4.0 6.3 ±4.0 6.1 ±3.9  6.3 ± 4.3 6.9 ±4.1* 5.9 ± 3.6 6.9 ±4.5  6.4 ± 4.0 
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ICU mortality, n (%)a 2430 (17.9) 1178 (16.2) 186 (23.9)* 536 (26.7)* 174 (13.9) 63 (9.2)* 39 (19.8) 254 (18.3) 
Hospital mortality, n (%)a 3212 (23.7) 1610 (22.1) 221 (28.4)* 663 (33)* 240 (19.2) 101 (14.1)* 48 (24.4) 329 (23.7) 
ICU LOS, median [IQ]  9 [3 - 25] 10[2-28] 10[3-29]* 11[4-28]* 6[2-18]* 7[2-17]* 7[2-21] 9[3-23] 
Hospital LOS, median 
[IQ]  
20 [9 - 45] 22[10-49] 22[10-45] 20[9-46] 14[6-33]* 17[8-40]* 14[6-31]* 17[8-41]* 
Days in ICU before the 
study day, median [IQ]  
3[0 - 11] 3[1-11] 4[0-13] 4[1-12]* 2[0-7]* 3[1-8] 1[0-8]* 3[0-8] 
 a834 missing; *P < 0.05 vs Western Europe. 
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Table 8. Multivariable logistic regression analysis with hospital mortality as the dependent 
variablea 
 
  OR (95% CI) P value 
Type of admission    
       Elective surgery Reference NA 
       Medical admission 1.20 (1.01-1.43) 0.038 
       Emergency surgery 1.61 (1.38-1.87) <0.001 
       Trauma 1.34 (1.07-1.69) 0.012 
Source of admission   
       OR/recovery Reference NA 
       ER/ambulance 0.92 (0.79-1.08) 0.308 
       Hospital floor 1.38 (1.19-1.59) <0.001 
       Other hospital 0.97 (0.82-1.16) 0.755 
Comorbidities   
       COPD 1.21 (1.07-1.37) 0.002 
       Cancer 1.35 (1.17-1.55) <0.001 
       Heart Failure (NYHA III-IV) 1.44 (1.24-1.68) <0.001 
       Diabetes mellitus 0.98 (0.84-1.15) 0.829 
       Chronic renal failure 1.04 (0.89-1.23) 0.598 
       Cirrhosis 2.15 (1.68-2.74) <0.001 
       Hematologic cancer 1.17 (0.85-1.60) 0.330 
       HIV 0.97 (0.58-1.65) 0.921 
Age (per year) 1.01 (1.01-1.01) 0.001 
Male sex 0.99 (0.89-1.09) 0.781 
Mechanical ventilation 1.91 (1.71-2.13) <0.001 
Hemodialysis/hemofiltration 1.62 (1.39-1.89) <0.001 
SAPS II (per point) 1.06 (1.05-1.06) <0.001 
Infection 1.52 (1.37-1.69) <0.001 
aAdjusted for hospital and organizational factors and for geographical region.  
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Table 9. Multivariable logistic regression analysis with hospital mortality as the dependent 
variable in infected patientsa 
 
  OR (95% CI) P value 
Type of admission    
       Elective surgery Reference NA 
       Medical admission 0.93 (0.74-1.17) 0.534 
       Emergency surgery 1.20 (0.98-1.47) 0.075 
       Trauma 0.81 (0.59-1.11) 0.186 
Source of admission   
       OR/recovery Reference NA 
       Other 1.10 (0.76-1.59) 0.619 
       ER/ambulance 0.90 (0.73-1.10) 0.296 
       Hospital floor 1.33 (1.11-1.60) 0.002 
       Other hospital 0.90 (0.73-1.12) 0.360 
Comorbidities   
       COPD 1.15 (0.99-1.34) 0.072 
       Cancer 1.42 (1.19-1.7) <0.001 
       Heart Failure (NYHA III-IV) 1.43 (1.18-1.73) <0.001 
       Diabetes mellitus 1.00 (0.82-1.22) 0.996 
       Chronic renal failure 1.08 (0.89-1.32) 0.433 
       Cirrhosis 2.32 (1.71-3.15) <0.001 
       Hematologic cancer 1.26 (0.88-1.81) 0.208 
       HIV 0.77 (0.43-1.40) 0.394 
Age (per year) 1.01 (1.00-1.01) <0.001 
Male sex 1.00 (0.88-1.13) 0.998 
Mechanical ventilation 1.72 (1.49-1.99) <0.001 
Hemodialysis/hemofiltration 1.60 (1.34-1.92) <0.001 
SAPS II (per point) 1.05 (1.04-1.06) <0.001 
Microorganisms   
       S. aureus 0.81 (0.63-1.04) 0.095 
       MRSA 1.28 (0.93-1.77) 0.131 
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       S. epidermidis 0.87 (0.69-1.09) 0.228 
       S. pneumoniae 0.74 (0.50-1.08) 0.121 
       Enterococcus 1.38 (1.10-1.73) 0.005 
       Gram +ve others 0.96 (0.71-1.30) 0.790 
       E. coli 0.91 (0.75-1.10) 0.330 
       Enterobacter 1.19 (0.90-1.57) 0.219 
       Klebsiella spp 1.01 (0.82-1.24) 0.919 
       Pseudomonas spp 1.42 (1.20-1.68) <0.001 
       Acinetobacter spp 1.60 (1.26-2.02) <0.001 
       Gram -ve others 1.15 (0.96-1.38) 0.130 
       Anaerobes 0.91 (0.64-1.28) 0.580 
       Other bacteria 1.24 (0.70-2.20) 0.462 
       Candida 1.1 (0.92-1.32) 0.308 
       Aspergillus 1.95 (1.07-3.54) 0.028 
       Fungi: others 2.04 (1.05-3.98) 0.037 
       Parasites 1.45 (0.60-3.52) 0.415 
       Other organisms 0.96 (0.66-1.39) 0.827 
MRSA: methicillin-resistant S. aureus; aAdjusted for hospital and organizational factors and for 





Appendix: List of participating centers by country alphabetically 
Andorra: Hospital Nostra Senyora de Meritxell (A Margarit); Argentina: Centro de Educación 
Médica E Investigaciones Clínicas (R Valentini); Clinica de Especialidades Villa Maria (Z Alan 
Javier); Clínica Modelo de Morón (C Bevilacqua); Clinica Y Maternidad Suizo (M Curone); 
CMIC (R Rabuffetti); Hospital Aleman (P Comignani); Hospital Argerich (M Torres Boden); 
Hospital Britanico (F Chertcoff); Hospital Central de San Isidro (G Cardonatti); Hospital de 
Niños Dr. Héctor Quintana (F Adén); Hospital del Niño Jesús (L Marcos); Hospital Dr Pedro 
Ecay (M Dónofrio); Hospital Español de Mendoza (R Fernández); Hospital Español Medical 
Plaza (R Lamberghini); Hospital Internacional General de Agudos "José de San Matín" (S 
Balasini); Hospital Interzonal Dr. O.Alende (J Teves); Hospital Italiano de Buenos Aires (M Las 
Heras, J Sinner); Hospital Juan A. Fernández (D Ceraso); Hospital Municipal de Chivilcoy (D 
Curcio); Hospital Profesor Alejandro Posadas (L Aguilar); Hospital Provincial de Rosario (C 
Weller); Hospital Provincial del Centenario (L Cardonnet); Hospital Regional Rio Gallegos (R 
Santa Cruz); Hospital Regional Ushuaia (E Manrique); Hospital Universitario Austral (D 
Bernardez, T Iolster); Hospital Universitario Universidad Abierta Interamericana (G Chiappero); 
Instituto Privado del Quemado Med-Inter (D Curcio); Nuevo Hospital El Milagro (P Ramos); 
Ramos Mejia Hospital (J Vergara); Sanatorio Agote (I Moine); Sanatorio de la Trinidad Mitre (S 
Ilutovich); Sanatorio de Los Arcos (G Jannello); Sanatorio Dupuytren (M Waschbusch); 
Sanatorio Frangioli de Salud 2000 Srl (G Rios Picaza); Sanatorio Mater Dei (A Raimondi); 
Sanatorio Otamendi Y Miroli (M Miriam); Sanatorio Parque (L Carlos); Sanatorio San José (D 
Curcio); Armenia: Centro Gallego de Buenos Aires (M Caridi); Australia: Alfred Hospital (T 
Leong); Barwon Health (N Orford); Blacktown Hospital (G Reece); Box Hill Hospital (D 
Ernest); Cabrini Hospital (F Hawker); Concord Repatriation General Hospital (J Tan); Epworth 
Eastern Private Hospital (C Giannellis); Epworth Hospital Richmond (B Ihle); Flinders Medical 
Centre (A Bersten); Frankston Hospital (J McInnes); Gold Coast Hospital (M Tallott); John 
Hunter Hospital (B Mcfadyen); Joondalup Health Campus (J Vibert); Liverpool Hospital, Sydney 
South West Area Health Service (M Parr); Logan Hospital (K Tran); Mater Health Services (J 
Sutton); Mount Hospital (S Webb); Nambour General Hospital (N Groves); Nepean Hospital, 
NSW (L Cole); Prince Charles Hospital (D Long); Prince of Wales Hospital (F Bass); Princess 
Margaret Hospital For Children (S Erickson); Royal Brisbane and Womens' Hospital (J Lipman); 
Royal Children’s Hospital, Brisbane (D Long); Royal Children’s Hospital, Melbourne (C 
Delzoppo); Royal Darwin Hospital (J Thomas); Royal Perth Hospital (G Dobb); Royal Prince 
Alfred Hospital (M Daley); Sir Charles Gairdner Hospital (B Roberts); St John of God Hospital, 
Subiaco (S Webb); St Vincent’s Hospital, Melbourne (J Santamaria); Sydney Children’s Hospital 
(J Young); The Children’s Hospital at Westmead, Sydney (M Festa); The John Flynn Private 
Hospital (R Holland); The Prince Charles Hospital (D Mullany); The Queen Elizabeth Hospital 
(P Williams); The Townsville Hospital (M Corkeron); The Wollongong Hospital (M Gales); 
Westmead Hospital (A Banerjee); Women’s and Children’s Hospital, Adelaide (M Yung); 
Austria: University Hospital Innsbruck (N Mutz, M Hiesmayr); General Hospital (P Faybik); 
Hospital Hietzing (R Fitzgerald); Krankenhaus Barmherzige Brüder Linz (F Firlinger); 
Krankenhaus Der Barmherigen Brueder Wien (G Zasmeta); Krankenhaus Der Barmherzigen 
Brüder St. Veit (M Zink); Krankenhaus Der Barmherzigen Schwestern Linz (W Sieber); 
Krankenhaus Steyr (J Hildegard); Landeskrankenhaus Klagenfurt (R Bakondy); 
Landeskrankenhaus Stolzalpe (J Schlieber); Landeskrankenhaus Deutschlandsberg (G 
Filzwieser); Medical University Innsbruck (R Beer, M Joannidis); Medical University of Vienna 
(T Staudinger); Otto-Wagner Hospital (R Schuster); Unfallkrankenhaus Meidling Der Auva (W 
Scherzer); University Hospital (K Smolle); Wilhelminenspital (S Fitzal); Bangladesh: Central 
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Hospital Limited (R Manzoor); Belgium: A.I.T. (J Brunain); Ambroise Paré (D Alain); Asz-Aalst 
(G Huylenbroeck); Az Groeninge Kortrijk (M Van der Schueren); Az Maria Middelares (H 't 
kindt); Az Sint Jozef Malle (E Slock); Az Sint Lucas (D Rijckaert); Az St Augustinus (J 
Raemaekers); Az St Jan Av (M Bourgeois); Az Vesalius (I Van Cotthem); Az Damiaan Oostende 
(G Nackaerts); C.H.N.D.R.F. (D Gusu); Centre Hospitalier de Mouscron (G Philippe); CH 
Libramont (V Olivier); Chirec - Braine-L'Alleud (H Lignian); CHPLT Verviers (P Michel); CHR 
Citadelle (V Fraipont); CHR Haute Senne Soignies (M Vander Stappen); CHR St Joseph Mons-
Warquignies (F Forêt); CHU Brugmann (D De Bels, J Devriendt, J Massaut); CHU Charleroi (B 
Patrick); CHU Saint-Pierre (A Roman); CHU Sart Tilman, Liège (B Lambermont); Clinique 
Sainte Elisabeth (A De Meulder); Clinique Notre Dame (V Frederic); Clinique Notre-Dame de 
Grâce (T Sottiaux); Clinique Saint Luc, Bouge (P Ruyffelaere); Cliniques de L'Europe, St-Michel 
(V Collin); Cliniques de L'Europe, Ste Elisabeth (S Anane); Hôpital Francais (P Kleiren); Hôpital 
Saint-Joseph (M Simon); Hornu (M Shahram); Imeldaziekenhuis (E Frans); Institut Jules Bordet 
(G Leroy, T Berghmans); Jan Yperman Hospital (R Joseph); Olv Ter Linden Ziekenhuis, Knokke 
(J Eerens); Saint Luc University Hospital (P Laterre); Sint Augustinus, Veurne (B Lagrou); St 
Vincent (R Rutsaert); St-Jozefkliniek Bornem-Willebroek (W Pisarek); UCL Mont-Godinne (A 
Dive); Universitair Ziekenhuis Gent (J De Waele); University Hospital Brussels (H Spapen); 
University Hospital of Liege (P Damas); Erasme University Hospital (JL Vincent); ZNA 
Stuivenberg (M Malbrain); Belize: Universal Health Services, Medical Center (J Hidalgo); 
Brazil: Bandeirantes Hospital (M Baptista); Barra Dor Hospital (D Salgado); Biocor Instituto (M 
Braga); Casa de Saude Sao Jose Caxias (C Avila); Centro Hospitalar Unimed (G Westphal); 
Centro Integrado de Atençaõ À Saúde -Unimed Vitória (E Caser); Clínica São Vicente da Gávea 
(A Alves); Complexo Hospitalar Santa Casa de Porto Alegre (G Friedman); Erasto Gaertner 
Hospital (M Luz); Federal University of Sao Paulo (M Assuncao); Fundacao Hospital de Clinicas 
Gaspar Vianna (H Reis); Fundação Hospitalar Do Estado de Minas Gerais - Fhemig (A Gomes); 
Fundação Pio Xii (U Silva); UNIFESP (W Nogueira Fh); Hopital das Clínicas - FMUSP (S El-
Dash); Hospital Padre Albino-Faculdade de Medicina de Catanduva (J Valiatti); Hospital Alberto 
Cavalcanti (A Barbosa); Hospital Badim (C Coelho); Hospital Cardiotrauma Ipanema (M 
Knibel); Hospital Carlos Fernando Malzoni (C Minelli); Hospital Da Cidade de Passo Fundo (J 
Caovilla); Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de 
São Paulo (G Teixeira); Hospital das Clínicas, Universisty of São Paulo (A Hovnanian); Hospital 
das Nacoes (A Rea-Neto); Hospital de Base-Famerp (S Lobo); Hospital de Clínicas Mario Lioni 
(M Lugarinho); Hospital de Clínicas Niterói (P Souza); Hospital de Doenças Tropicais de 
Goiânia (D Ferreira); Hospital do Cancer / Uopeccan (P Duarte); Hospital do Trabalhador (M 
Oliveira); Hospital dos Servidores do Estado Rio de Janeiro (J Marques); Hospital E Maternidade 
São José (R Machado); Hospital Estadual Diadema (P Rehder); Hospital Estadual do Grajau-
Unisa (S Mataloun); Hospital Evangelico (M Grilo); Hospital Evangelico do Rio de Janeiro (P 
Quesado); Hospital Geral de Pedreira (M Moock); Hospital Geral de São Mateus (F Ferreira); 
Hospital Geral Roberto Santos (J Teles); Hospital Israelita Albert Einstein (E Silva); Hospital 
Israelita Albert Sabin (C Coelho); Hospital Júlia Kubitschek (A Morais); Hospital Mater Dei (F 
Carvalho); Hospital Memorial Arthur Ramos (M Wanderley); Hospital Meridional (M Velasco); 
Hospital Moinhos de Vento (N Brandão da Silva); Hospital Municipal São José (J Feijó); 
Hospital Nossa Senhora Da Salete (P Duarte); Hospital Pasteur (V Souza Dantas); Hospital 
Português (J Teles); Hospital Pró-Cardíaco (R Costa Filho); Hospital Quinta D'Or (A Japiassu); 
Hospital Regional Antônio Dias (D Villela); Hospital Regional de Barbacena (C Santos); 
Hospital Salvador (R Passos); Hospital Samaritano (R Alheira-Rocha); Hospital Santa Izabel (R 
Silva); Hospital Santa Paula (J Houly); Hospital Sao Cristovao (J Aldrighi); Hospital São Lucas 
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(R Hatum); Hospital São Lucas da PUCRS (F Suparregui Dias); Hospital São Luiz - Unidade 
Itaim (L Ferreira); Hospital São Rafael (L Ferro); Hospital São Vicente de Paulo (J Gomez); 
Hospital Universitário Clementindo Fraga Filho - Ufrj (R Fleury); Hospital Universitario da 
Universidade  Federal do Rio de Janeiro (C David); Hospital Universitário de Santa Maria (T 
Resener); Hospital Universitário do Oeste do Paraná (P Duarte); Hospital Universitário Lauro 
Wanderley - UTI Adulto (C Mendes); Hospital Universitario Regional de Maringa (A Germano); 
Hospital Vita Curitiba (M Oliveira); Hospital Vivalle (F De marco); Instituto de Espquisa Clinica 
Evandro Chagas (A Japiassu); Instituto Do Coração - HC-FMUSP (S Lage); Instituto Nacional 
de Cancer (J Salluh); Irmandade Santa Casa de Misericordia de Porto Alegre (A Torelly); 
Luxemburgo Hospital (R Sad); Mternidade Odete Valadares (A Barbosa); Prontocor Lagoa (G 
Oliveira); Samaritano Hospital (R Lima); Santa Casa Da Misericórdia de São João del Rei (J 
Paranhos); Santa Casa de Misericordia de Passos (M Oliveira); Santa Casa de Porto Alegre (M 
Rocha); Sao Sebastiao Hospital (W Bitencourt); São Sebastião Hospital (W Bitencourt); 
Universidade Federal Do Parana (A Rea-Neto); University of Londrina (C Grion); University of 
Sao Paulo (D Forte); Uti Da Disciplina de Clínica Médica-Unifesp (H Guimarães); Vitória Apart 
Hospital (C Piras); Bulgaria: Mbal Ruse (L Stephanova); Multiprofile Hospital of Active 
Treatment, Ruse (L Lyubenov); Uh St. Ekaterina (G Tsarianski); Univerisity Hospital (G 
Dimov); Canada: Capital Health-Queen Elizabeth II Health Sciences Centre (R Green); Centre 
Hospitalier Régional de Lanaudière (J Levasseur); Children’s Hospital of Eastern Ontario (R 
Ward); CHU Sherbrooke (O Lesur); Hôpital Charles Lemoyne (G Poirier); Mount Sinai Hospital 
(R Wax); Royal Jubilee Hospital (G Wood); St. Joseph’s Healthcare (D Cook); St. Michael’s 
Hospital (J Marshall); Toronto General Hospital (M Herridge); Toronto Western Hospital (N 
Ferguson); Victoria General Hospital (G Wood); Chile: Clinica Alemana de Santiago (M 
Espinoza); Clinica las Condes (S Valdés jimenez); Hospital Clínico de la Pontificia Universidad 
Católica de Chile (A Bruhn); Hospital del Trabajador (J Micolich); Hospital Dr G. Fricke (S 
Galvez); Hospital El Pino (I Escamilla Leon); China: Beijing Chaoyang Hospital (Q Zhan); 
Beijing Tongren Hospital (Y Xu); Chinense Pla General Hospital (Y Zhao); Fuxing Hospital, 
Capital Medical University (L Zhang); Guangdong Provincial People’s Hospital (T Qin); Peking 
Union Medical College Hospital (B Du); Peking University People’s Hospital (M Li); Ren Ji 
Hospital,Shanghai Jiao Tong University (X Wang); The Affiliated Hospital of Ningxia Medical 
College of China (Y Jing); The First Affiliate Hospital of China Medical University (Z Zhang); 
The First Affiliated Hospital of Dalian Medical University (W Xianyao); The First People’s 
Hospital of Nantong, Jiangsu (F Li); Zhong-Da Hospital and School of Clinical Medicine, 
Southeast University (Y Congshan); Colombia: Clinica  General del Norte (C Rebolledo); 
Clinica Central del Quindio (D Diaz); Clinica Medellin (R Murillo Arboleda); Clinica Saludcoop 
(C Rebolledo); Clinica Santa Isabel de Valledupar. (A Arias Antun); Fundación Hospital San 
Carlos (G Montenegro); Fundacion Valle del Lili (M Granados); Hospital Bocagrande de 
Cartagena ( ); Hospital Departamental de Villavicencio (N Perez); Hospital El Tunal (G Libreros 
Duque); Hospital San Jose de Bogota (M Coral); Hospital Santa Clara (G Ortiz); Costa Rica: 
Hospital Calderón Guardia CCSS (D Rodriguez); Croatia: Hospital for Infectious Diseases (B 
Barsic); Sveti Duh General Hospital, School of Medicine, Zagreb (M Cubrilo-Turek); University 
Hospital Centre (I Gornik); University Hospital Zagreb (M Grljusic); Cuba: Hospital 
Universitario Arnaldo Milian Castro (A Caballero lopez); Hospital Universitario Dr. Gustavo 
Aldereguía Lima (M Iraola ferrer); Czech Republic: Centre of Cardivascular and Transplant 
Surgery (P Pavlik); Charles University Teaching Hospital, Hradec Kralove (J Manak); Charles 
University Medical School and Teaching Hospital (J Radej); Faculty General Hospital, Charles 
University Prague (J Belohlavek); Faculty Hospital Brno (P Sevcik); Faculty Hospital Olomouc 
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(L Blahut); General Teaching Hospital of 1St Faculty and Charles University (D Tyl); Horovice 
Hospital (J Steinbach); Klaudians Hospital (I Herold); Krajska Nemocnice Liberec (I Zykova); 
Nemocnice V Usti Nad Orlici (D Prchal); St. Anne’s University Hospital Brno (T Bartosik); 
University Hospital Brno (M Kolarova); University Hospital Olomouc (R Hájek, J Kohoutová, O 
Marek); University Hospital Ostrava (P Hon); University Hospital Plzen (I Chytra); Denmark: 
Århus University Hospital (H Betsch); Næstved Hospital (B Fogh); Rigshospitalet (K Espersen); 
Sygehus Fyn (K Jacobsen); Vejle Sygehus (P Berezowicz); Ecuador: Carlos Andrade Marín 
Hospital (F Guerrero); Clinica La Merced (E Salgado); Hospital Eugenio Espejo (D Barahona); 
Hospital General de Las Fuerzas Armadas del Ecuador Hg-1 (H Del pozo sanchez); Hospital 
Metropolitano (M Jibaja); Egypt: Dar Alfouad Hospital (A Alansary); Estonia: East Tallinn 
Central Hospital (A Reintam); Tartu University Hospital (J Starkopf); Finland: Helsinki 
University Central Hospital (V Harjola); France: AP-HP, CHU Jean Verdier (L Tual); 
Assistance Publique-Hôpitaux de Marseille, CHU Nord (M Leone); Centre Hospitalier 
Dunkerque (M Serge); Centre Hospitalier Universitaire (P Michel); Centre Hospitalier (O Leroy); 
Centre Hospitalier D'Auch (L Mallet); Centre Hospitalier de Blois (B Marc); Centre Hospitalier 
de Fougères (D Dormoy); Centre Hospitalier de Niort (H Pascal); Centre Hospitalier Dr 
Schaffner (L Tronchon); Centre Hospitalier du Pays D'Aix (B Garrigues); Centre Hospitalier 
Region Annecy (C Santré); Centre Hospitalier Universitaire Amiens (H Dupont); Centre 
Hospitalier Universitaire de Bicêtre (J Duranteau); Centre Hospitalier Universitaire Reims (A 
Leon); CH Colmar (L Henry); CHG Armentieres (C Canevet); CHU Angers (L Dube); CHU 
Angers (H Julien); CHU Bicetre (A Nadia); CHU Brest (B Francois); CHU de Bordeaux (J 
Gérard); CHU Dijon Hopital Général (M Freysz); CHU Hôtel Dieu - APHP (G Remy); CHU 
Nantes (Y Blanloeil); Clinique Ambroise Paré (P Squara); General Hospital (J Korach); Grenoble 
University Hospital (M Durand); Groupe Hospitalier du Havre (C Gabriel); Hia Laveran (P Eric); 
Hopital Antoine Béclère APHP (F Jacobs); Hopital Bichat (R Bronchard); Hôpital Claude Huriez, 
Centre Hospitalier Régional Universitaire de Lille (E Kipnis); Hopital Cochin Paris (M Moussa); 
Hôpital de Hautepierre (A Launoy); Hopital de la Croix Rousse (C Guérin); Hôpital Edouard 
Herriot (P Vanhems); Hôpital Maison Blanche (A Wynckel); Hôpital Raymond Poincaré (B 
Clair); Hôpital Saint-Louis (E Azoulay); Hôpital Tenon (J Fulgencio); Hôpitaux Civils de Colmar 
(Y Gottwalles); Hôpitaux Universitaires de Strasbourg (T Krummel); Hospices Civils de Lyon (A 
Lepape); La Rochelle Hospital (O Lesieur); Lariboisiere University Hospital (D Payen); Poissy 
Hospital (O Hérvé); Polyclinique Saint André (J Farkas); Rangueil Hospital (P Cougot); 
Réanimation Chirurgicale (Y Malledant); University Hospital of Bordeaux Haut-Lèvéque (O 
Joannes-Boyau); Germany: Academic Hospital Solingen (T Standl); Ameos Klinikum 
St.Salvator Halberstadt GMBH (U Sierig); Asklepios Fachkliniken München-Gauting (J 
Geiseler); Asklepios Klinik Langen (H Hopf); Behandlungszentrum Vogtareuth (M Burgau); 
Bergmannsheil Bochum (E Conrad-Opel); Bethanien-Krankenhaus (C Hermann); 
Bundeswehrkrankenhaus Ulm (M Ventzke); Charite/Campus Virchow-Klinikum (T Henneberg); 
Charite Berlin-Buch (H Loeser); Charité Campus, Mitte (C Spies); Charité Campus, Virchow 
Klinikum (C Spies); Charite Campus, Virchow (F Esposito); Charité Universitätsmedizin Berlin 
(H Zuckermann-becker); Clemenshospitl (R Scherer); Dominikus Krankenhaus (A Pauer); Drk-
Kliniken Mark Brandenburg (S Kljucar); Drk-Krankenhaus Ratzeburg (K Delfs); Elisabeth-
Krankenhaus Essen (E Blank); Ev. Kliniken Bonn Betriebsstätte Waldkrankenhaus (J Busch); 
Ev.-Freikirchliches Krankenhaus Rüdersdorf (K Wendt); Evang. Krankenhaus Mülheim (J 
Leßmann); Evangelische Kliniken Bonn Wadkrankenhaus (J Busch); Evangelisches Krankenhaus 
Bielefeld (F Bach); Friedrich Schiller University, Jena (Y Sakr); Gemeinschaftskrankenhaus 
Herdecke (T Berlet); Georg-August University of Göttingen (A Kernchen); Georg-August-
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University of Göttingen (M Quintel); Hanse-Klinikum Wismar (D Holst); Heart clinic of the 
University of Munich (E Kilger); Helfenstein Klinik (T Holubarsch); Helios Klinik Lengerich (C 
Raufhake); Helios-Klinikum Berlin-Buch (R, Kuhlen, C Stolt); Helios Klinikum Emil Von 
Behring (A Lubasch); Helios Klinikum Erfurt Gmbh (A Meier-Hellmann); Helios Klinikum 
Wuppertal Barmen (G Woebker); Henriettenstift (C Scharnofske); Herz-Jesu-Krankenhaus (M 
Breyer); Hochtaunus Kliniken Bad Homburg (T Risch); Hospital Links Der Weser (C Manhold); 
Icu In Drk Kliniken Mark Brandenburg (S Kljucar); J.W. Goethe - University Medical School 
Frankfurt Am Main (D Meininger); Johanniter Krankenhaus Bonn (C Greive); Johanniter 
Krankenhaus Stendal Ggmbh (J Rau); Jung-Stilling-Krankenhaus (A Seibel); Katharinenhospital 
(A Henn-beilharz); Katholisches Krankenhaus Hagen (R Wolbert); Krankenhaus Prignitz 
Gemmeinnützige GMBH (T Scherke); Klinik Am Eichert (J Martin); Klinik Für Herzchirurgie 
(M Rudolph); Klinik Füranästhesie, Operative Intensivmedizin U. Schmerztherapie (J Gleißner); 
Kliniken Ludwigsburg-Bietigheim GMBH (M Wolf); Kliniken Maria Hilf (F Schleibach); 
Klinikum Augsburg (U Jaschinski); Klinikum Bad Salzungen (A Lunkeit); Klinikum Darmstadt 
(M Welte); Klinikum Der J.W. Goethe-Universität (T Bingold); Klinikum Der Stedt Wolfsburg 
( ); Klinikum Emden (K Kogelmann); Klinikum Forchheim (F Fischer); Klinikum Fuerth (B 
Fischer, M Schmid); Klinikum Grosshadern, Universität München (M Klein); Klinikum 
Harlaching Städtisches Klinikum Muenchen (A Bechtold); Klinikum Hildesheim (K Bodmann); 
Klinikum Kaufbeuren (J Klasen); Klinikum Landsberg (H Meyrl); Klinikum Lippe - Detmold (J 
Goetz); Klinikum Ludwigsburg (G Geldner); Klinikum Luedenscheid (T Helmes); Klinikum 
Meiningen GMBH (N Jensen); Klinikum Minden (H Eickmeyer, W Lengfelder); Klinikum 
Nürnberg (B Langenstein); Klinikum Rechts Der Isar (R Bogdanski); Klinikum Rechts Der Isar 
Der Technischen Universität München (S Jelen-Esselborn, A Umgelter); Klinikum Region 
Hannover (F Dörr); Klinikum Region Hannover Krankenhaus Großburgwedel (K Lüttje); 
Klinikum Region Hannover, Krankenhaus Oststadt-Heidehaus (D Heinemeyer); Klinikum 
Starnberg (M Uhl); Klinikum Stuttgart - Olgahospital (P Schirle); Klinikum Suedstadt (H 
Benad); Klinikum Traunstein (M Glaser); Klinikum Uelzen (W Panzer); Klinikum Worms (E 
Huettemann); Klinikverbund St. Ansgar, Krankenhaus Bassum (R Stierwaldt); Klinikverbund 
Süd-West (M Schappacher); Knappschaftskrankenhaus Bochum-Langendreer (E Müller); 
Krankenhaus Freyung (Rural Hospital) (W Stadlmeyer); Krankenhaus Lübbecke (M Fantini); 
Krankenhaus Mol GMBH Strausberg (B Dummer); Krankenhaus Nordwest (M Thörner); 
Krankenhaus Nordwest (V Jost); Krankenhaus Reinbek (T Loerbroks); Kreisklinik Trostberg (T 
Glück); Kreiskrankenhaus Bergstrasse (R Zimmermann); Kreiskrankenhaus Calw (R Clement); 
Kreiskrankenhaus Mechernich GMBH (R Hering); Kreiskrankenhaus Nagold (T Klinger); 
Kreiskrankenhaus Rottweil (J Mehl); Kreiskrankenhaus St. Marienberg Helmstedt (H Polozek); 
Leopoldina-Krankenhaus (A Rothhammer); Ludmillenstift (R Seidler); Lukas-Krankenhaus 
Bünde (P Lorenz); Lungenfachklinik Amsee Waren Mueritz (M Lutze); Marienhospital Bruehl 
(M Euler); Marienkrankenhaus Schwerte (M Heintz); Martin Luther Universität Halle (M 
Winkler); Medizinische Klinik (M Angstwurm); Mlu Halle-Wittenberg (K Krohe); Mueritz-
Klinikum Waren (T Treu); Neurological Intensive Care Unit (T Steiner); Oberschwabenklinik 
Wangen (S Locher); Orthopädische Klinik Markgröningen (A Walz); Ostalb-Klinikum Aalen (P 
Zahn); Otto-Von-Guericke Universität Magdeburg (W Brandt); Scivias-Krankenhaus St. Josef 
(M Marks); Ska-Bileelfeld-Mitte (F Henning); St. Antonius Hospital (U Janssens); St. 
Hildegardis Krankenhaus Mainz (M Luethgens); St. Johannes Krankenhaus (W Theelen); St. 
Johannes-Hospital (M Sydow); St. Johannes-Hospital (M Weber); St. Josef-Hospital, Ruhr-
Universität Bochum (A Meiser); St. Josefs-Hospital (C Deutschmann); St. Joseph Krankenhaus 
(C Buttner); St.-Marien Hospital Lünen (M Jokiel); St. Marienhospital Hamm (C Bozzetti); St. 
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Vincentius Kliniken (B Jürgen); St.-Elisabeth Krankenhaus Köln-Hohenlind (F Fiedler); St.-
Vincentius-Krankenhaus Speyer (K Wresch); Städtischen Kliniken Neuss - Lukaskrankenhaus (A 
Kremer); Städtisches Klinikum Karlsruhe (H Bleier); Städtisches Klinikum Wiesbaden, Dr.-
Horst-Schmidt-Kliniken Hsk (M Rueckert); Staedtisches Klinikum Guetersloh (H Ditter); 
Staedtisches Klinikum Muenchen Gmbh - Klinikum Harlaching (C Peckelsen); Staedtisches 
Klinikum Muenchen Gmbh/Klinikum Bogenhausen (P Friederich); Staedtisches Klinikum 
München - Klinikum Neuperlach (K Weber); Tübingen University Hospital (W Krueger); Ubbo-
Emmius-Klinik Aurich (R Lowack); Überlingen Hospital (A Michalsen); Uniklinikum Dresden 
(M Ragaller); Universitaetsklinikum des Saarlandes (A Groeschel); Universitaetsklinikum 
Mannheim (T Friedrich); Universität Rostock (M Hinz); Universitätsklinikum Der Martin-
Luther-Universität Halle-Wittenberg (A Christel); Universitätsklinikum Dresden Carl Gustav 
Carus (M Ragaller); Universitätsklinikum Leipzig Aör (T Hartwig); Universitätsmedizin Berlin 
Charité Campus Benjamin Franklin (S Vögeler); University (M Weiss); University Childrens 
Hospital Hauner (K Reiter); University Hospital (T Schwab); University Hospital Cologne (U 
Trieschmann); University Hospital Dusseldorf (D Kindgen-milles); University Hospital Giessen 
and Marburg Gmbh - Giessen (J Engel); University Hospital Lübeck (B Sedemund-adib); 
University Hospital Mainz (M Lauterbach); University Hospital Marburg (M Max); University 
Hospital Muenster (T Volkert); University Hospital of Essen (C Waydhas); University Hospital 
of Mannheim (S Hien); University Hospital of Munich, LMU (J Briegel); University Hospital of 
Regensburg (V Guralnik); University Hospital Rwth Aachen (N Zoremba); University Hospital 
Tübingen (R Riessen); University Hospital Würzburg (W Müllges); University Medical Center 
Hamburg-Eppendorf (A Nierhaus); University of Erlangen (R Strauss); University of Freiburg (S 
Utzolino); University of Giessen (J Thul); University of Greifswald (P Abel, M Gründling, W 
Keßler); University of Heidelberg (K Scheuren); University of Leipzig (E Lothar, U Kaisers, D 
Schmitt, D Schneider); University of Rostock (D Vagts); University of Saarland (H Rensing); 
University Hospital Essen (B Schoch); Universty Hospital (K Kopp); Vivantes - Klinikum 
Neukoelln (H Gerlach); Vivantes Klinikum Prenzlauer Berg (M Corea); Vivantes-Klinikum Am 
Urban (A Uhrig); Westkuestenklinikum Heide (S Schroeder); Westküstenklinikum Heide (F 
Jordan); Westpfalz-Klinikum Kaiserslautern (T Huber); Zentralöklinikum Augsburg (M 
Bittinger) Greece: Ahepa University Hospital (E Sofianos); Athens University Medical School 
(A Armaganidis); Evangelismos Hospital (C Routsi); G.Papanikolaou (M Bitzani); General 
Hospital of Rethymno (A Chalkiadaki); Henry Dunant Hospital (A Michalopoulos); 
Hippokrateion Hospital Thessaloniki (E Mouloudi); Kat General Hospital (E Ioannidou); Kat 
Hospital (P Myrianthefs); Kat Hospital, Athens (D Koulenti); Konstantopoulio General Hospital 
(I Karampela); Lamia General Hospital (G Kyriazopoulos); Red Cross Hospital of Athens (K 
Mandragos); Thriassio Hospital of Eleusis (P Clouva-molyvdas); University Hospital of Ioannina 
(A Moraiti); University Hospital of Alexandroupolis (I Pneumatikos); University Hospital of 
Rion, Patras (K Filos); University Hospital of Thessaly (Larissa) (E Zakynthinos); University of 
Athens, Medical Shcool (A Kotanidou); Xanthi General Hospital (A Vakalos) Hong Kong: 
Northern District Hospital (A Cheng); Princess Margaret Hospital and Yan Chai Hospital (T 
Buckley); The Chinese University of Hong Kong (C Gomersall) Hungary: National Institute of 
Neurosurgery (K Kiss); Péterfy Hospital Budapest (P Tamási); Saint George Hospital Hungary 
(A Sarkany); Semmelweis University (A Csomos); University of Szeged (É Zöllei) India: 
Advanced Medicare Research Institute (S Todi); B.D.Petit Parsee General Hospital (F Udwadia); 
Bhailal Amin General Hospital (R Shah); Bombay Hospital (P Amin); Breach Candy Hospital 
Trust (F Udwadia); Care Hospitals (S Samavedam); Christian Medical College (A Mathai); 
Cumballa Hill Hospital & Heart Institute (M Patil); Deenanath Mangeshkar Hospital (S Jog); Dr. 
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S. N. Medical College (M Gurjar); Escorts Heart Institute & Research Centre (M Vats); Fortis 
Healthcare (A Varma); Global Hospitals (P Gopal); Hinduja Hospital & Medical Research Center 
(F Kapadia); Indraprastha Apoolo Hospitals (R Chawla); Jehangir Hospital (S Iyer); Kalinga 
Hospital (S Sahu); Kasturba Hospital (C Bakshi); Lokmanya Care Hospital (D Ambike); Max 
Super Speciality Hospital (D Govil); Medical Trust Hospital, Cochin (V Karipparambath); Nh 
Hospital (J Chacko); Ruby Hall Clinic (P Sathe); Rungta Hospital (N Rungta); Saifee Hospital (C 
Jani); Seth Ramdas Shah Memorial Hospital & Research Centre (A Bhome); Shree Medical 
Foundation (S Prayag); Sir Ganga Ram Hospital (S Ray); Sundaram Medical Foundation (R 
Rajagopalan); Tata Memorial Hospital (J Divatia); Wockhardt Hospital (R Da costa); Wockhrdt 
Hospital (T Shyam Sunder) Indonesia: Bintaro International Hospital (P Wibowo); Hasan 
Sadikin Hospital (T Maskoen); Pantai Indah Kapuk Hospital (T Sugiman) Islamic Republic of 
Iran: Imamreza Hospital (S Nowruzinia); Laleh Hospital (A Lotfi); Tehran University of Medical 
Sciences (A Mahmoodpoor) Ireland: Amnch (M Donnelly); Cork University Hospital (D Breen); 
Mater Misercordiae University Hospital (S Ng); University Hospital Galway (J Bates) Israel: 
Hadassah Medical Center (C Sprung); Haemek Medical Center (A Lev); Kaplan Medical Center 
(E Kishinevsky); Rabin Medical Center (J Cohen); Soroka Medical Center (S Sofer) Italy: A.O 
Niguarda (S Vesconi); A.O. Ospedale Di Circolo Di Busto Arsizio (S Greco); A.O. Treviglio-
Caravaggio (M Borelli); Anestesia E Rianimazione 2 Prof.De Gaudio (P Cecilia); Arnas 
Ospedale Civico (M Sapuppo); ASL 10 (A Lazzero); ASL 10 Florence Hospital San Giovanni Di 
Dio (V Mangani); Azienda Ospedaliera Desenzano (N Petrucci); Azienda Ospedaliera Di 
Melegnano (M Minerva); Azienda Ospedaliera G. Rummo (E De blasio); Azienda Ospedaliera 
Polo Universitario San Paolo (S Marzorati); Azienda Ospedaliera Santa Maria Alle Scotte (R 
Rosi); Azienda Ospedaliera Universitaria P.Giaccone Policlinico (A Giarratano); Azienda 
Ospedaliera-Universitaria Udine (O Margarit); Azienda Ospedaliero -Universitaria (A Guberti); 
Azienda Ospedaliero-Universitaria S.M.Misericordia (S Scolz); Clinica San Gaudenzio (E 
Stelian); Fondazione IRCCS Policlinico San Matteo (V Emmi); Fondazione Ospedale Maggiore 
Policlinico, Mangiagalli Regina Elena (M Caspani); Fondazione Poliambulanza (A Rosano); H 
San Gerardo (C Abbruzzese); Hospital Panico Tricase (S Colonna); Humanitas Gavazzeni (R 
Ceriani); II Faculty of Medicne I University of Rome- Osp. S.Andrea (R De Blasi); S. Salvatore 
Hospital (L Panella); IRCCS Casa Sollievo Della Sofferenza (F Borrelli); Istituto Nazionale 
Tumori Regina Elena (P Lorella); KH Brixen (H Ruatti); Osepdali Riuniti Di Ancona (C Munch); 
Ospedale "Ca Foncello" - Treviso (Italia) (C Sorbara); Ospedale "Santa Croce" - ASL 8 (G 
Fiore); Ospedale Bufalini-Cesena (A Chieregato); Ospedale Di Circolo E Fondazione Macchi (V 
Conti); Ospedale Di Massa (A Guadagnucci); Ospedale Di Piacenza (P Mario); Ospedale 
Ferrarotto (M Locicero); Ospedale Maggiore Ausl Bologna (I Marri); Ospedale Maggiore 
Policlinico Milano (A Sicignano); Ospedale Maggiore Policlinico, Mangiagalli E Regina Elena, 
IRCCS Milano (V Conte); Ospedale Mugello Azienda Sanitaria Firenze (R Oggioni); Ospedale 
Niguarda Ca Granda, Milano (A De Gasperi); Ospedale Oncologico Regionale - Centro Di 
Riferimento Oncologico Della Basilicata (P De negri); Ospedale Provinciale Pistoia (G 
Santagostino); Ospedale S. Gerardo (F Roberto); Ospedale San Raffaele (G Marino); Ospedele 
Vittorio Emanuele (G Castiglione); P.O. San Severo Asl Fg (D Sforza); S. Camillo Hospitql (N 
Giuseppe); San Martino Hospital (M Bassetti); Seconda Università Degli Studi Di Napoli (F 
Ferraro); Sesto San Giovanni Hospital (S Clementi); Teaching Hospital Careggi (D Alessandro); 
Terapia Intensiva - Aso S. Giovanni Battista Di Torino - Ospedale Molinette (P Cotogni, MV 
Ranieri); Università Cattolica (M Antonelli); Universita' Cattolica Del S. Cuore (L Martinelli); 
University-Hospital Careggi, Florence, (L Gianesello); University Hospital Policlinico Di 
Catania (A Gullo); University of Rome "La Sapienza" (A Morelli); UTI Trapianti (G 
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Biancofiore); University of Udine (G Della Rocca) Japan: Kyoto Prefectural University of 
Medicine (S Hashimoto); Nagoya University Hospital (M Onodera); Oosaka-Fu Saiseikai Suita 
Hospital (A Kobayashi); Sanai Hospital (T Shinozuka); Tokushima University School of 
Medicine (H Imanaka); Tokyo Medical University, Hachioji Medical Center (T Ikeda); Tokyo 
Women’s Medical University (A Yaguchi) Latvia: Hospital of Traumatology and Orthopedics (I 
Misane); 7th Hospital of Riga (A Piebalga) Lebanon: Lebanese Canadian Hospital (A 
Moughaghab) Lithuania: Medicine University of Kaunas (V Pilvinis); Vilnius University 
Emergency Hospital (S Vosylius); Vilnius University Hospital Santariskiu Clinics (M Balciunas, 
G Kekstas) Luxembourg: Centre Hospitalier de Luxembourg (H Margaret); Clinique Ste Thérèse 
(M Klop) Macedonia: Clinic For Infectious Diseases (K Grozdanovski); General Hospital Stip (B 
Eftimova) Malaysia: Faculty of Medicine, Universiti Kebangsaan Malaysia (S Wafa); Hospital 
Pulau Pinang (C Lim); Hospital Tengku Ampuan Afzan, Kuantan, Pahang (M Mat nor); Kuala 
Lumpur Hospital (L Tai); National Heart Institute (S Syed Mohd Tahir); Sarawak General 
Hospital (N Idris); Sultanah Aminah Hospital (C Tan) Malta: St Luke’s Hospital (M Borg); 
Mexico: Angeles Metropolitano Hospital (E Manzo); Centro Medico Lic.Adolfo Lopez Mateos 
(H Gutierrez Morales); Hgr 25 Imss Zaragoza (P Miguel); Hospital Angeles Clinica Londres (A 
Villagomez); Hospital Angeles del Carmen (A Bassols); Hospital Civil de Guadalajara "Fray 
Antonio Alcalde" (G Aguirre); Hospital Español de México (U Cerón); Hospital General 
Bernardo J. Gastelum (J Lopez ramos); Hospital General del Estado "Dr Ernesto Ramos Bours", 
Hermosillo Sonora Mexico (J Monjardín); Hospital General Regional de Leon (E Bermudez 
Aceves); Hospital General Reynosa (F Gonzalez Salazar); Hospital Juan I.Menchaca Hospital 
Civil de Guadalajara (D Rodriguez Gonzalez); Hospital Juárez de México (M Poblano-Morales); 
Hospital Mèdica Sur (F Ramirez); Hospital O´horan (M Cetina); Hospital Privado de Hermosillo 
(J Navarro); Hospital Regional 1° Octubre, Issste (A Villagomez Ortiz); Hospital San Jose Tec 
Monterrey (V Sanchez); Hospital Universitario "Dr. Jose E. Gonzalez" (U Chavarria); IMSS (O 
Fernandez-Ponce); Iner (H Serna secundino); Instituto de Salud del Estado de Aguascalientes (O 
Leonardo); Instituto Mexicano del Seguro Social (R Diego Manuel, J Mijangos); Issemym 
Medical Center (G Vazquez de Anda); Mexican Red Cross (E Martin); Ocq Hospital (P 
Gutierrez); Secretaria de Salud del Gobierno del Distrito Federal (I López Islas); Servicios de 
Salud En Yucatan (L Soberanes) Montenegro: Clinical Center of Montenegro (P Ljubica)  
Morocco: Chu Ibn Sina (A Sbihi); Polyclinique CNSS Derb Ghallef (B Ouahid); Réanimation 
Médicale, Hôpital Ibn Sina (M Naoufel) Netherlands: Academic Medical Center (A De Pont); 
Amphia Hospital (P Rosseel); Antoni Van Leeuwenhoek Ziekenhuis (J Ten Cate); Beatrix 
Zienhuis Rivas Zorggroep (G Van Berkel); Canisius Wilhelmina Ziekenhuis (S Corsten); 
Erasmus Mc University Medical Center (J Bakker); Hagaziekenhuis (J Vogelaar); Hofpoort 
Hospital Woerden (H Blom); Isala Clinics (H Kieft); Medical Center Leeuwarden (M Kuiper); 
Medisch Spectrum Twente (A Gille); Radboud University Nijmegen Medical Centre (P 
Pickkers); Rode Kruis Ziekenhuis (J Vet); Slingeland Ziekenhuis (J Ammann); 
Spaarneziekenhuis (S Den Boer); St. Antonius Ziekenhuis (R Wesselink); St.Elisabeth Hospital 
(B Speelberg); Twenteborg Hospital Almelo (C Pham); University Hospital Groningen (M 
Rodgers); University Hospital Maastricht (D Bergmans); Vu University Medical Center (J 
Groeneveld) New Zealand: Auckland City Hospital (C Mcarthur); Auckland City Hospital (M 
Rachael); Christchurch (J Mehrtens); Dunedin Hospital (L Celi); Hawkes Bay Hospital (R 
Freebairn); Middlemore Hospital (N Rankin); Nelson Marlborough District Health Board (C 
Heffernan); Palmerston North Hospital (G McHugh); Starship Children’s Hospital (J Beca); 
Waikato Hospital (F Van haren); Wellington Public Hospital (B Barry); Whangarei Base 
Hospital (M Kalkoff) Norway: Aker University Hospital (R Loevstad); St Olavs University 
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Hospital (P Klepstad); Sykehuset Asker Og Bærum Hf (P Erno); Sykehuset I Vestfold Hf , 
Toensberg (A Junker) Pakistan: Armed Forces Institute of Cardiology (S Naqvi); Jinnah Hospital 
Lahore Pakistan (I Javed) Panama: Complejo Hospitalario Metropolitano (J Sinclair) Peru: 
Hipolito Unanue Hospital (R Rivera); Hospital  Regional Honorio Delgado (C Chavez); Hospital 
Alberto Sabogal Sologuren (Z Donayre Taber); Hospital Dos De Mayo (R Quispe Sierra); 
Hospital Edgardo Rebagliati Martins (J Muñoz); Hospital Maria Auxiliadora (J Galvez Ruiz); 
Hospital Nacional Almanzor Aguinaga Asenjo Essalud Chiclayo (J Fang Li); Hospital Nacional 
Arzobispo Loayza (M Candiotti Herrera); Hospital Víctor Lazarte Echegaray (A Arroyo); 
Instituto de Salud del Niño (R Becerra); Navy Hospital (J Meza); Peruvian Air Force Central 
Hospital (M Mayorga) Poland: 4th Military Clinical Hospital (P Garba); Academic Centre for 
Maritime and Tropical Medicine AMG (J Kot); Barlicki University Hospital, University of 
Medical Science, Lodz, (T Gaszynski); Boleslaw Szarecki Teaching Hospital No. 5 of The 
Medical University In Lodz (M Piechota); Clinical Hospital No 2 (S Renata); Collegium 
Medicum Jagiellonian University (P Müller); Institute of Cardiology (J Stepinska); J. 
Brudzinski’s Hospital In Gdynia (K Jacek); Jagiellonian University (T Cieniawa); Karol 
Marcinkowski University of Medical Sciences (A Mikstacki, B Tamowicz); Poznan University of 
Medical Sciences (A Bartkowska-Sniatkowska); Silesian University of Medicine (E Karpel); 
University Hospital Bydgoszcz Cm Umk (K Kusza); University Hospital No 2 (P 
Smuszkiewicz); University Hospital Warsaw (M Mikaszewska-Sokolewicz); Wojewodzki 
Szpital Specjalistyczny (R Goraj); Wroclaw Medical University (A Kubler) Portugal: Centro 
Hospitalar Alto Ave (A Bártolo); Centro Hospitalar Cova Da Beira (M Castelo-Branco Sousa); 
Centro Hospitalar Tras Os Montes E Alto Douro (F Esteves); Chlo-Hospital S Francisco Xavier 
(A Martins); H S Joao (T Oliveira); Hospital Cuf Infante Santo (P Ponce); Hospital Curry Cabral 
(L Mourão); Hospital Da Luz (C Febra); Hospital de Egas Moniz (E Carmo); Hospital de S. José 
(V Lopes); Hospital de São Francisco Xavier (P Póvoa); Hospital de São José (A Rezende); 
Hospital Divino Espirito Santo (H Costa); Hospital Do Litoral Alentejano (P Moreira); Hospital 
Dr. José Maria Grande, Portalegre (F Pádua); Hospital Fernando Fonseca (A Leite); Hospital 
Garcia Orta (E Almeida); Hospital Geral de Santo António (M Alves); Hospital Pulido Valente 
(A Sousa, L Telo); Hospital S. Joao (C Dias, J Paiva); Hospital Sao Bernardo (R Ribeiro); 
Hospital São Sebastião, Epe (P Amaro); Hospital Sto Antonio (A Carneiro); Hospital de St. 
Antonio Dos Cqpuchos (R Moreno); Instituto Português de Oncologia de Lisboa (M Bouw); 
University Hospital St Maria (C Franca) Qatar: Alkhor Hospital (A Ibrahim); Romania: "Maria 
Sklodowska Curie" Children’s Emergency Hospital,  Bucharest (R Tabacaru); Department Public 
Hospital (V Ionita); Fundeni Institute (D Tulbure); Institute of Cardiovascular Disease (D 
Filipescu); Institutul de Boli Cardiovasculare Si Transplant Tg. Mures (S Pascanu); Spitalul "Sf. 
Spiridon" (I Grigoras); University Emergency County Hospital (S Copotoiu) Russia: Bakoulev 
Scientific Center For Cardiovascular Surgery (D Popov); City Clinical Hospital (E Lebedev); 
City Hospital (I Olga); City Hospital #7 (A Yaroshetskiy); Clinical Hospital N°40 (T 
Lugovkina); Ekaterinburg. University Hospital N°40 (B Dmitry); Izhevsk State Medical 
Academy (O Malinin); Moscow Children’s Surgery Institut (A Lekmanov) Saudi Arabia: Alawi 
Tunsi Hospital (M Abulmagd); King Abdulaziz Medical City (Y Arabi); King Abdulaziz 
University Hospital (J Alhashemi); King Fahad Specialist Hospital Dammam (A Ali); King 
Faisal Specialist Hospital (K Maghrabi); Kingdom Hospital (A Debek); Riyadh Millitary 
Hospital (M Malik) Serbia: Clinical Center Nis (R Jankovic); Clinical Centre of Serbia (I 
Palibrk); Dedinje Cardiovascular Institute (V Maravic-stojkovic); KBC Bezanijka Kosa (V 
Malenkovic); Military Medical Academy, Belgrade (M Surbatovic); Unuiversity of Belgrade (V 
Bumbasirevic) Singapore: Changi General Hospital (N Lim); Kk Hospital (T Loh); Tan Tock 
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Seng Hospital (H Tan) Slovakia: Fakultna Nemocnica Nitra (H Sekeresova); FNSP Bratislava-
Hospital Ruzinov (J Koutun); Madical Faculty Hospital Kosice (J Firment); Nusch Bratislava (P 
Malik); Reiman Hospital (S Trenkler) Slovenia: Clinic Center Ljubljana (I Muzlovic); General 
Hospital Novo Mesto (L Kosec, B Ozek); General Hospital Slovenj Gradec (D Kasnik); 
University Clinic of Respiratory and Allergic Diseases (V Tomic); University Clinical Center 
Ljubljana (R Knafelj); University Medical Center Ljubljana (V Svigelj) South Africa: 1 Military 
Hospital (H Du Plessis); Groote Schuur Hospital (R Raine); Johannesburg Hospital (S 
Bhagwanjee, G Richards); Johannesburg Hospital (S Bhagwanjee); Johannesburg Hospital 
Trauma Unit (J Goosen); Unitas Hospital (J De Jager); Wits Donald Gordon Medical Center (G 
Schleicher) Spain: Althaia (O Rubio); Bellvitge University Hospital (R Mañez); Centro Medico 
Delfos (M Burgueño Campiñez); Clinica Moncloa (M Alvarez); Clinica Rotger (R Jorda); 
Clinica Santa Elena (E Naveira-Abeigón); Clinica Universitaria de Navarra (P Monedero); 
Complejo Hospitalario de Pontevedra (E Alemparte-Pardavila); Fundacion Hospital Alcorcon (S 
Garcia del Valle); Fundacion Jimenez Diaz (C Perez Calvo); H Vall Hebron (M Palomar); H.U. 
Virgen de Las Nieves- H. Traumatología Y Rehabilitación (F Guerrero); Hospital "Virgen de La 
Concha" - Zamora (A Caballero Zirena); Hospital Arnau de Vilanova (M Arribas); Hospital Can 
Misses (E Bustamante Munguira); Hospital Casa de Salud (J Ruiz); Hospital Central de Asturias 
(L Iglesias); Hospital Clinic (E Zavala); Hospital Clinic de Barcelona (M Valencia); Hospital 
Clinico San Carlos (A Blesa Malpica); Hospital Clinico San Carlos (F Martinez-Sagasti, M 
Nieto); Hospital Clinico Universitario (G Aguilar); Hospital Clinico Universitario de Santiago (F 
Martinon-Torres); Hospital Comarcal Vinaros (C Lorente); Hospital de  Navarra (J Insausti); 
Hospital de Antequera (R Vegas Pinto); Hospital de Basurto (I Santos); Hospital de Fuenlabrada 
(A Escriba); Hospital de Galdakao (P Olaechea); Hospital de La Merced (E Muñoz); Hospital de 
Manacor (E Antón Caraballo); Hospital de Mostoles (P Galdos-Anuncibay); Hospital de Sagunto 
(V Lopez Camps); Hospital de Tortosa Verge de La Cinta (F Esteban-Reboll); Hospital del Sas 
de Jerez (E Angel); Hospital Donostia (L Bocero); Hospital Dr Peset (A Ibañez); Hospital G. 
Yagüe (L Pueyo); Hospital General (L María Jesús); Hospital General de Asturias (L Iglesias); 
Hospital General de Ciudad Real (J Silva); Hospital General de Granollers (P Garro); Hospital 
General de La Palma (L Ramos-gómez); Hospital General de L'Hospitalet (A Rovira); Hospital 
General de Vic (M Martin Delgado); Hospital General Salud "Obispo Polanco" (J Monton Dito); 
Hospital General Universitario de Albacete (F Garcia); Hospital General Universitario de 
Alicante (J Navarro); Hospital General Universitario de Elche (J Latour-Perez); Hospital General 
Universitario de Guadalajara (A Albaya); Hospital General Universitario Gregorio Marañon (A 
Bustinza); Hospital Gran Canaria "Dr Negrín" (J Sole-violán); Hospital Marques de Valdecilla (P 
Ugarte Peña); Hospital Maz (I Yuste); Hospital Parque San Antonio (J De Rojas Román); 
Hospital Sabadell (J Vallés); Hospital Sant Joan de Déu (E Esteban); Hospital Sant Pau (E 
Quintana Tort-Martorell); Hospital Santa María del Rosell (M Moreno); Hospital Santa Maria 
Madre-Complejo Hospitalario de Ourense (V López Ciudad); Hospital Santiago Apostol (A 
Manzano Ramirez); Hospital Sevilla-Aljarafe (J Sánchez-Olmedo); Hospital Son Llàtzer (M 
Borges); Hospital Terrassa (J Amador Amerigo); Hospital Torrecardenas (F Guerrero Gomez); 
Hospital Universitaio 12 de Octubre (J Montejo González); Hospital Universitari de Girona 
Doctor Josep Trueta (J Sirvent); Hospital Universitari Germans Trias I Pujol (E Mesalles 
Sanjuan); Hospital Universitario Arnau de Vilanova (F Barcenilla-Gaite); Hospital Universitario 
de Canarias (N Serrano); Hospital Universitario de Getafe (E Cerdá); Hospital Universitario de 
Valme (A Lesmes Serrano); Hospital Universitario Doce de Octubre (C Garcia-Fuentes); 
Hospital Universitario Infanta Crsitina (J Macias Pingarrón); Hospital Universitario Nªsra de 
Candelaria (E Espinosa); Hospital Universitario Principe de Asturias (M Sanchez Garcia); 
 47 
Hospital Universitario Reina Sofía, Murcia (F Felices); Hospital Universitario Virgen de La 
Victoria (M de la Torre-Prados); Hospital Univesitario Puerto Real (H Maria Jesus); Hospital 
Valle del Nalon (V Luis); Hospital Virgen Arrixaca (R Jara); Hospital Xanit Internacional (M 
Briones Lopez); Hospital Xeral Cies (P Posada); Hu La Paz (B Galvan); Hu La Paz (F Mariscal); 
Joan Xxiii University Hospital (J Rello); Morales Meseguer (B Gil); Puerta del Mar Universitary 
Hospital (R Sierra); Rio Hortega University Hospital (J Rico-Feijoo); San Pedro de Alcantara 
Hospital (C Corcobado Márquez); Servicio Navarro de Salud.Hospital Virgen del Camino (J 
Izura); Uci H. U. Salamanca (J González); Universitary Hospital Dr. Peset (J Soto Ibáñez) Sudan: 
Soba University Hospital (H Agabani) Sweden: Anestesikliniken (P Petersen); Centralsjukhuset  
Karlstad (L Johansson); University Hospital, Linköping (H Blomqvist, B Peterzén, N Wyon); 
Göteborg (I Lindström); Kärnsjukhuset Skövde (A Paulsson); Karolinska University Hospital 
Huddinge (C Agvald-Ohman); Karolinska University Hospital, Solna (J Petersson); Lund 
University Hospital (H Friberg); Malmoe University Hospital (V Einar); Op/ Iva Kliniken (F 
Hammarskjöld); Ostersund Hospital (M Schindele); Ostra Hospital, Göteborg (S Arvidsson); 
Sahlgrenska University Hospital (J Sellgren); Söder Hospital (Södersjukhuset) (J Hulting); 
Sodersjukhuset (J Häggqvist); Sollefteå Hospital (J Rudenstam); Sunderby Hospital (D Lind); 
The Queen Silvia Children’s Hospital (E Kokinsky); Thoracic Intensive Care, Karolinska 
Hospital (A Owall); Umeå University Hospital (S Jacobson); University Hospital (H 
Stiernstrom); University Hospital of Örebro (A Nydahl) Switzerland: CHUV, Lausanne (P 
Eggimann); University of Geneva (R Stocker); Hirslanden Klinik Beau-Site (G Loderer); 
Kantonsspital Liestal (R Loetscher); Kantonsspital Luzern (A Mehlig); Lindenhofspital (K Heer); 
Neuchâtel (H Zender); Ospedale Civico Di Lugano (S Cottini); Regional Hospital Mendrisio (A 
Pagnamenta); Stadtspital Triemli (G Eich); Swiss Paraplegic Centre (P Felleiter); University 
Hospital Zurich (M Marco); University Hospitals of Geneva (J Pugin) Taiwan: Changhua 
Christian Hospital (W Shu-Hui); Kaohsiung Veterans General Hospital (K Hsieh) Thailand: 
Faculty of Medicine Siriraj Hospital (P Toomtong); Prince of Songkla University (B 
Khwannimit); The Bnh Hospital (P Kietdumrongwong) Tunisia: Children’s Hospital of Tunis (A 
Khaldi); Hopital Aziza Othmana (A Messadi); Military Hospital of Tunis (I Labbene); Mongi 
Slim Hospital (N Frikha) Turkey: Acibadem Kadikoy Hospital (K Atalan); Acibadem Bakirkoy 
Hospital (C Ates); Acibadem Bursa Hospital (A Kahveci); Acibadem Kozyatagi Hospital (H 
Fistikci); Ankara Univercity (A Kaya); Ankara University Medical Faculty, Ibni Sina Hospital (E 
Ozgencil); Ataturk University Medical Faculty (M Kizilkaya); Dicle University Medical School 
(M Bosnak); Dokuz Eylul University (H Bodur); Dokuz Eylul University School of Medicine (M 
Akan); Erciyes University Medical Faculty (M Guven); Gazi University School of Medicine (M 
Turkoglu); Hacettepe University Hospital (A Topeli); Inonu University Medical Faculty (T 
Togal); Istanbul Faculty of Medicine (N Uzel); Istanbul Medical Faculty (I Akinci, N Cakar, S 
Tugrul); Istanbul University Cerrahpasa Medical School (O Demirkiran); Izmir Ataturk Training 
and Resarch Hospital (T Adanir); Memorial Hospital (K Dogruer); Okmeydani Teaching & 
Research Hospital (A Turkmen); Okmeydani Teaching & Research Hospital (H Guven); 
Ondokuz Mayis University, Medical Faculty (F Ulger); Selcuk University Meram Faculty of 
Medicine (S Kocak) Ukraine: Lugansk City Hospital No. 7 (Y Nalapko); Lugansk District 
Hospital (Y Nalapko) United Arab Emirates: Al-Mafraq Hospital (S Rady); Department of 
Health & Medical Services (A Alsabbah); Dohms (N Elahi); Dubai Hospital (H Al rahma); 
Tawam Hospital (M Rahman, S Kashef) United Kingdom: Aberdeen Royal Infirmary (B 
Cuthbertson); Addenbrookes Hospital (K Gunning); Barnsley Hospital (Y Myint); Bristol Royal 
Infirmary (J Bewley); Cambridge University Teaching Hospitals (R Burnstein); Christie Hospital 
(P Haji-Michael); Dumfries and Galloway Royal Infirmary (D Wrathall); Kent and Canterbury 
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Hospital (L Folan); Freeman Hospital (I Nesbitt); Friarage Hospital Northallerton (A 
Ratnaparkhi); Frimley Park Hospital (S Pambakian); Glasgow Royal Infirmary (M Booth); Great 
Western Hospital Swindon (M Watters); Guys and St Thomas' NHS Foundation Trust (T Sherry); 
Huddersfield Royal Infirmary (U Buehner); Hurstwood Park Neurosurgical Centre (C Barrera 
Groba); James Paget University Hospital (P Bothma); John Radcliffe Hospital (N George, J 
Millo; Kettering General Hospital (L Hollos); Lothian University Hospitals Trust (S Mclellan); 
Macclesfield District  General Hospital (J Hunter); Manchester Royal Infirmary (M Garrioch, N 
O'Keeffe); Medway NHS Trust (N Divekar); Morriston Hospital (S Eggert); New Cross 
Hospital,Wolverhampton. (S Smith); Newcastle General Hospital (A Vincent); Newham 
University Hospital Trust (P Withington); NHS Tayside (C Macmillan); Northampton General 
Hospital (R Webster); Papworth Hospital (A Vuylsteke); Peterborough Hospitals (B Appadu); 
Princess Royal Hospital (C Barrera groba); Queen Alexandra Hospital, Portsmouth (P 
McQuillan); Queen Elizabeth Hospital (M Blunt); Queen Elizabeth Medical Center, Birmingham 
(N Parekh); Rotherham DGH (D William); Royal Berkshire Hospital (C Jones); Royal Blackburn 
Hospital (A Krige); Royal Bournemouth NHS Foundation Trust (M Schuster-Bruce); Royal 
Cornwall Hospital (J Boyden); Royal Devon & Exeter NHS Foundation Trust (C Boulanger); 
Royal Infirmary of Edinburgh (D Swann); Royal Liverpool University Hospital (J Walker); 
Royal Marsden Hospital (T Wigmore); Royal Shrewsbury Hospital (R Law); Royal Sussex 
County Hospital (F Baldwin); South Tyneside Hospital (C Muench); Southmead Hospital (S 
Robinson); St George’s Hospital (A Crerar-Gilbert, A Rhodes); St Helens and Knowsley 
Hospital (T Mahambrey); St John’s Hospital (L Cameron); St. James’s University Hospital (J 
Thornton); St. Mary’s Hospital (M Stotz); St. Peters Hospital (M Russell); Stirling Royal 
Infirmary (A Longmate); Tameside General Hospital (R Kitson); Taunton & Somerset NHS 
Trust  (B Browne); The Hillingdon Hospital (A Thorniley); The James Cook University Hospital 
(I Gonzalez); Torbay Hospital (M Swart); University College Hospital (M Singer); University 
Hospital Birmingham (N Gautam); University Hospital of South Manchester (V Prasad); 
University Hospitals Coventry & Warwickshire Nhs Trust (D Watson); West Middlesex 
University Hospital (T Szakmany); West Suffolk Hospital (J Cardy); Western Infirmary Glasgow 
(A Binning); Wexham Park Hospital (R Loveland); Wirral Hospitals Nhs Trust (J Gannon); 
Wolverhampton Hospital (G Martinelli); Wythenshawe Hospital (P Nightingale); Yeovil District 
Hospital (J Howes) United States: Baystate Medical Center (J Steingrub); Denver Health Medical 
Center (L Ammons); Emory University Hospital - Micu (M Fisher); Englewood Hopital Medical 
Center (N Gandhi); Grady Memorial Hospital-Emory University (G Martin); Hospital of The 
University of Pennsylvania (C Deutschman); Ihc Health Services Inc, Dba Lds Hospital (N 
Dean); Inova Fairfax Hospital (C Michetti); Los Angeles County+University of Southern 
California Medical Center (H Belzberg); Lsuhsc Shreveport (K Hutchinson); Maine Medical 
Center (T Van der kloot); Mayo Clinic (B Afessa); Mount Sinai School of Medicine (D 
Kaufman); Nassau University Medical Center (J Iqbal); New York University (D Ost); 
Northwestern University (M West, R Wunderink); Northwestern University Feinberg School of 
Medicine Critical Care (S Afifi); Olive View Ucla Medical Center (S Stein); Oregon Health & 
Science University (D Hagg); Orlando Regional Medical Center (E Jimenez); Penn State Hershey 
Medical Center (S Blosser); Rochester General Hospital (S Chhangani); Rush University Medical 
Center (R Kleinpell); Rutland Regional Medical Center (H Reich); Scott and White Hospital (E 
Fileds); Sharp Memorial Hospital (D Willms); South Texas Veterans Health Care System  (P 
Castellanos-Mateus); St. Joseph Medical Center Fhs (L Melnik); Texas Tech University Health 
Sciences Center (L Oud); The Methodist Hospital (E Chi); The Methodist Hospital (R Halfon); 
The University of Mississippi Medical Center (A Badr); The University of Texas Health Science 
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Center At San Antonio (P Castellanos-mateus); University of Chicago (A Pohlman); University 
of Cincinnati (R Branson); University of Kansas Hospital (S Simpson); University of Miami 
School of Medicine (D Kett); University of Michigan (T Jacobs, P Park, W Wahl); University of 
Texas Health Science Center at San Antonio (C Patricia); University of Toledo Medical Center (J 
Hammersley, T Papadimos); University of Virginia (R Sawyer); Uthsc At Memphis - Regional 
Medical Center (Site) (A Freire); Veterans Caribbean Healthcare System (W Rodriguez); 
Washington Hospital Center (A Ryan); West Suburban Medical Center (B Margolis); Winthrop 
University Hospital (M Groth) Uruguay: Amecom (H Escanda); Comta (J Baraibar); Hopital 
Policial (D Paciel); Hospital Maciel (H Bagnulo); Hospital Tacuarembo (F Hitta); Médica 
Uruguaya Corporación de Asistencia Médica (P Nadales); Sanatorio Americano - Femi (H 
Albornoz) Venezuela: Hospital Dr Luis Ortega (Z Salmen); Hospital Unversitario de Caracas (C 
Pacheco) Vietnam: Bach Mai Hospital (T Bui); Franco Vietnamese Hospital (F Potie); Ninh 
Thuan Hospital (C Nguyen Huu)  
 
